https://curecurrent.com/trials/qtc-study-of-rosi-xr-in-healthy-volunteers-64908 https://curecurrent.com/trials/prediction-of-cognitive-properties-of-new-drug-candidates-for-neurodegenerative-diseases-in-early-clinical-development-64909 https://curecurrent.com/trials/effect-of-activity-on-sleep-of-cognitively-impaired-veterans-64910 https://curecurrent.com/trials/telehealth-education-program-for-caregivers-of-veterans-with-dementia-64911 https://curecurrent.com/trials/testing-the-effectiveness-of-telephone-support-for-dementia-caregivers-64912 https://curecurrent.com/trials/nurse-managed-clinic-for-dementia-patients-and-family-caregivers-64913 https://curecurrent.com/trials/supporting-caregivers-of-persons-with-dementia-a-pilot-study-64914 https://curecurrent.com/trials/pain-management-and-behavioral-outcomes-in-patients-with-dementia-64915 https://curecurrent.com/trials/raloxifene-for-women-with-alzheimer-s-disease-64916 https://curecurrent.com/trials/intervention-programs-for-decreasing-caregiver-burden-in-caregivers-of-patients-with-dementia-64917 https://curecurrent.com/trials/single-and-repeated-dosing-study-to-assess-the-safety-and-the-concentration-time-profile-of-sar228810-in-alzheimer-s-pat-64918 https://curecurrent.com/trials/a-phase-i-clinical-study-randomized-single-blind-placebo-controlled-multiple-doses-dose-escalation-study-of-the-safety-t-64919 https://curecurrent.com/trials/a-positron-emission-tomography-pet-study-evaluating-brain-metabolism-of-a-medical-food-in-alzheimer-s-disease-64920 https://curecurrent.com/trials/single-ascending-dose-study-of-biib037-in-participants-with-alzheimer-s-disease-64921 https://curecurrent.com/trials/effect-of-ly450139-on-the-long-term-progression-of-alzheimer-s-disease-64922 https://curecurrent.com/trials/effects-of-strengthening-exercise-on-the-brain-for-early-dementia-and-normative-older-adults-64923 https://curecurrent.com/trials/cellular-proteome-from-leukocytes-of-glaucoma-patients-in-comparison-with-patients-with-alzheimer-s-disease-64924 https://curecurrent.com/trials/early-diagnosis-of-alzheimer-like-dementia-benefit-of-mri-and-pet-imaging-64925 https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-aricept-in-patients-with-severe-alzheimer-s-disease-who-are-living-in-skilled-nurs-64926 https://curecurrent.com/trials/study-of-repetitive-transcranial-magnetic-stimulation-rtms-as-add-on-treatment-for-early-alzheimer-s-disease-64927 https://curecurrent.com/trials/effects-of-ly450139-on-the-progression-of-alzheimer-s-disease-as-compared-with-placebo-64928 https://curecurrent.com/trials/mk0249-for-the-symptomatic-treatment-of-alzheimer-s-disease-mk0249-011-64929 https://curecurrent.com/trials/amylo-d-load-in-elderly-population-effect-of-cognitive-reserve-64930 https://curecurrent.com/trials/a-safety-study-of-ttp4000-in-subjects-with-alzheimer-s-disease-64931 https://curecurrent.com/trials/study-to-evaluate-the-effects-of-food-ingestion-on-the-pharmacokinetics-of-chf-5074-in-healthy-young-male-subjects-64932 https://curecurrent.com/trials/safety-pharmacokinetics-and-pharmacodynamics-study-of-treatment-with-chf-5074-in-healthy-young-male-subjects-64933 https://curecurrent.com/trials/study-to-evaluate-safety-pharmacokinetics-and-pharmacodynamics-of-chf5074-in-healthy-young-male-subjects-64934 https://curecurrent.com/trials/evaluation-of-effects-of-multiple-dose-regimens-of-chf-5074-on-potential-biomarkers-of-neurodegeneration-in-subjects-wit-64935 https://curecurrent.com/trials/treatment-of-elderly-subjects-with-psychosis-and-behavioral-disturbances-associated-with-dementia-of-the-alzheimer-s-typ-64936 https://curecurrent.com/trials/multi-modality-mri-study-on-prediction-for-mild-cognitive-impairment-conversion-64937 https://curecurrent.com/trials/patients-with-alzheimer-disease-spouse-carers-and-risk-of-institutionalization-a-prospective-observational-cohort-study-64938 https://curecurrent.com/trials/safety-efficacy-and-dose-titration-of-sodium-oligo-mannurarate-capsule-on-mild-to-moderate-alzheimer-s-disease-64939 https://curecurrent.com/trials/a-two-part-single-dose-study-of-the-pharmacokinetics-of-mk-8931-in-subjects-with-renal-insufficiency-mk-8931-009-p08535-64940 https://curecurrent.com/trials/efficacy-study-of-a-zt-1-implant-in-patients-suffering-from-alzheimer-s-disease-64941 https://curecurrent.com/trials/evaluation-of-zk-6032924-in-probable-alzheimer-s-disease-patients-versus-healthy-volunteers-and-the-radiation-dosimetry-64942 https://curecurrent.com/trials/liwa-for-treatment-of-alzheimer-patients-64943 https://curecurrent.com/trials/amyloid-imaging-and-safety-study-of-acc-001-in-subjects-with-mild-to-moderate-alzheimer-s-disease-64944 https://curecurrent.com/trials/telephone-resources-and-assistance-for-caregivers-trac-64945 https://curecurrent.com/trials/long-term-extension-study-evaluating-safety-tolerability-and-immunogenicity-of-acc-001-in-japanese-subjects-with-mild-to-64946 https://curecurrent.com/trials/collaboration-between-department-of-old-age-psychiatry-and-nursing-homes-64947 https://curecurrent.com/trials/physical-exercise-as-an-additional-treatment-for-alzheimer-disease-64948 https://curecurrent.com/trials/effect-of-physical-exercise-in-alzheimer-patients-64949 https://curecurrent.com/trials/home-evaluation-of-exit-barriers-in-wandering-64950 https://curecurrent.com/trials/f-18-av-45-uptake-spot-sign-presence-and-cerebral-amyloid-angiopathy-caa-in-primary-intracranial-hemorrhage-ich-64951 https://curecurrent.com/trials/evaluate-the-efficacy-and-safety-of-abt-126-in-subjects-with-mild-to-moderate-alzheimer-s-disease-64952 https://curecurrent.com/trials/3-month-study-of-msdc-0160-effects-on-brain-glucose-utilization-cognition-safety-in-subjects-with-alzheimer-s-disease-64953 https://curecurrent.com/trials/outcome-predictors-of-a-cognitive-intervention-in-amci-64954 https://curecurrent.com/trials/a-study-to-investigate-the-safety-tolerability-and-pharmacokinetics-of-jnj-54861911-in-healthy-volunteers-compared-with-64955 https://curecurrent.com/trials/mechanisms-of-insulin-facilitation-of-memory-64956 https://curecurrent.com/trials/evaluate-the-efficacy-and-safety-of-abt-126-in-subjects-with-mild-to-moderate-alzheimer-s-disease-on-stable-doses-of-ace-64957 https://curecurrent.com/trials/meditation-or-education-for-alzheimer-caregivers-64958 https://curecurrent.com/trials/effects-of-sage-on-memory-and-mental-performance-in-alzheimer-s-disease-patients-64959 https://curecurrent.com/trials/evaluating-cerebrospinal-fluid-biomarkers-in-alzheimer-s-progressive-supranuclear-palsy-subjects-and-controls-64960 https://curecurrent.com/trials/memantine-plus-es-citalopram-in-elderly-depressed-patients-with-cognitive-impairment-64961 https://curecurrent.com/trials/the-use-of-eeg-in-alzheimer-s-disease-with-and-without-scopolamine-a-pilot-study-64962 https://curecurrent.com/trials/evaluation-of-electronic-florbetapir-18f-interpretation-training-in-japanese-physicians-64963 https://curecurrent.com/trials/effects-of-memantine-on-magnetic-resonance-mr-spectroscopy-in-subjects-at-risk-for-alzheimer-s-disease-64964 https://curecurrent.com/trials/capacity-assessment-in-persons-with-alzheimer-s-disease-64965 https://curecurrent.com/trials/a-study-to-assess-effects-of-clarithromycin-on-pharmacokinetics-of-jnj-54861911-in-healthy-male-participants-64966 https://curecurrent.com/trials/alzheimer-disease-rehabilitation-s-intervention-at-home-64967 https://curecurrent.com/trials/a-study-to-evaluate-bioavailability-food-effect-safety-and-tolerability-of-a-solid-dosage-formulation-of-jnj-54861911-in-64968 https://curecurrent.com/trials/the-paco-study-personnalit-alzheimer-comportement-64969 https://curecurrent.com/trials/imaging-characteristics-of-florbetapir-18f-in-patients-with-frontotemporal-dementia-alzheimer-s-disease-and-normal-contr-64970 https://curecurrent.com/trials/efficacy-and-safety-of-talsaclidine-in-patients-with-mild-to-moderate-dementia-of-alzheimer-type-64971 https://curecurrent.com/trials/efficacy-and-safety-of-talsaclidine-free-base-in-patients-with-mild-to-moderate-dementia-of-alzheimer-type-64972 https://curecurrent.com/trials/valproate-in-dementia-valid-64973 https://curecurrent.com/trials/follow-up-trial-to-assess-the-long-term-safety-and-tolerability-of-talsaclidine-in-patients-with-mild-to-moderate-dement-64974 https://curecurrent.com/trials/minocycline-in-patients-with-alzheimer-s-disease-64975 https://curecurrent.com/trials/a-study-of-semagacestat-for-alzheimer-s-patients-64976 https://curecurrent.com/trials/dha-docosahexaenoic-acid-an-omega-3-fatty-acid-in-slowing-the-progression-of-alzheimer-s-disease-64977 https://curecurrent.com/trials/cognitive-rehabilitation-in-alzheimer-s-disease-64978 https://curecurrent.com/trials/a-multiple-dose-study-of-gantenerumab-in-japanese-alzheimer-apos-s-disease-patients-64979 https://curecurrent.com/trials/home-based-assessment-for-alzheimer-disease-prevention-64980 https://curecurrent.com/trials/alzheimer-s-disease-neuroimaging-initiative-grand-opportunity-64981 https://curecurrent.com/trials/adni-alzheimer-s-disease-neuroimaging-initiative-64982 https://curecurrent.com/trials/a-safety-tolerability-and-pharmacokinetics-study-of-jnj-54861911-in-healthy-japanese-male-participants-64983 https://curecurrent.com/trials/the-predictive-factors-of-good-clinical-response-to-cholinesterase-inhibitors-in-alzheimer-disease-and-mixed-dementia-64984 https://curecurrent.com/trials/assess-the-prognostic-usefulness-of-flutemetamol-18f-injection-for-identifying-subjects-with-amnestic-mild-cognitive-imp-64985 https://curecurrent.com/trials/study-evaluating-single-ascending-doses-of-aab-001-vaccine-sad-japanese-patients-with-alzheimers-disease-64986 https://curecurrent.com/trials/a-pilot-study-of-tdcs-for-mild-to-moderate-alzhemier-s-disease-64987 https://curecurrent.com/trials/early-diagnosis-of-alzheimer-s-disease-clinical-neuropsychological-and-neuroimaging-follow-up-of-a-cohort-of-patients-wi-64988 https://curecurrent.com/trials/performance-of-aclarusdx-a-blood-based-transcriptomic-test-for-ad-in-french-patients-newly-referred-to-a-memory-center-64989 https://curecurrent.com/trials/study-of-sta-1-as-an-add-on-treatment-to-donepezil-64990 https://curecurrent.com/trials/advance-study-alzheimer-disease-evaluation-in-clinical-practice-64991 https://curecurrent.com/trials/pharmacokinetic-interaction-between-azd3480-and-donepezil-64992 https://curecurrent.com/trials/escitalopram-for-the-treatment-of-depression-in-alzheimer-s-disease-64993 https://curecurrent.com/trials/effect-of-memantine-oral-pump-on-language-in-patients-with-probable-alzheimer-s-disease-64994 https://curecurrent.com/trials/delaying-the-progression-of-driving-impairment-in-individuals-with-mild-alzheimer-s-disease-64995 https://curecurrent.com/trials/a-study-versus-e2020-10mg-followed-by-an-open-label-extension-phase-to-explore-the-safety-of-e2020-sr-23-mg-in-japanese-64996 https://curecurrent.com/trials/normative-values-for-cognitive-testing-and-alzheimer-s-imaging-biomarkers-in-young-adults-64997 https://curecurrent.com/trials/a-24-week-efficacy-safety-and-tolerability-of-rivastigmine-patch-study-in-patients-with-probable-alzheimer-s-disease-64998 https://curecurrent.com/trials/effectiveness-of-a-brain-computer-interface-based-system-for-cognitive-enhancement-in-the-normal-elderly-64999 https://curecurrent.com/trials/phase-ii-study-of-florbetaben-bay-94-9172-pet-imaging-for-detection-exclusion-of-cerebral-amyloid-in-patients-with-proba-65000 https://curecurrent.com/trials/oxaloacetate-pharmacokinetics-and-safety-65001 https://curecurrent.com/trials/study-to-evaluate-the-safety-tolerability-and-the-effect-of-bms-241027-on-cerebrospinal-fluid-biomarkers-in-subjects-wit-65002 https://curecurrent.com/trials/proof-of-concept-study-of-cognitive-improvement-in-patients-with-alzheimer-s-disease-65003 https://curecurrent.com/trials/a-randomized-clinical-trial-of-vitamin-e-and-memantine-in-alzheimer-s-disease-65004 https://curecurrent.com/trials/physical-activity-training-program-for-patients-with-alzheimer-s-dementia-65005 https://curecurrent.com/trials/effects-of-exercise-on-cognitive-performance-of-patients-with-alzheimer-type-dementia-pilot-study-65006 https://curecurrent.com/trials/hippocampus-study-comparative-effect-of-donepezil-10mg-d-and-placebo-on-clinical-and-radiological-markers-65007 https://curecurrent.com/trials/hormone-and-information-processing-study-65008 https://curecurrent.com/trials/safety-study-of-trx0237-in-patients-already-taking-medications-for-mild-and-moderate-alzheimer-s-disease-65009 https://curecurrent.com/trials/comparison-of-23-mg-donepezil-sustained-release-sr-to-10-mg-donepezil-immediate-release-ir-in-patients-with-moderate-to-65010 https://curecurrent.com/trials/experimental-study-to-validate-the-therapeutic-game-conem-beta-65011 https://curecurrent.com/trials/experimental-study-of-the-impact-of-a-group-therapy-psychological-intervention-for-caregivers-of-alzheimer-s-disease-pat-65012 https://curecurrent.com/trials/alzheimer-and-sleep-65013 https://curecurrent.com/trials/azd3293-thorough-qt-study-in-healthy-male-volunteers-65014 https://curecurrent.com/trials/a-phase-i-clinical-dose-escalation-study-of-the-safety-tolerability-and-pharmacokinetics-of-donepezil-patch-in-healthy-m-65015 https://curecurrent.com/trials/delta-thc-in-dementia-65016 https://curecurrent.com/trials/citalopram-for-agitation-in-alzheimer-s-disease-65017 https://curecurrent.com/trials/florbetaben-bay94-9172-pet-positron-emission-tomography-imaging-in-mci-mild-cognitive-impairment-patients-65018 https://curecurrent.com/trials/long-term-use-of-galantamine-versus-nootropics-memory-enhancing-drugs-in-patients-with-alzheimer-s-dementia-under-condit-65019 https://curecurrent.com/trials/a-phase-i-open-label-single-center-study-to-assess-the-absorption-metabolism-and-excretion-of-14c-azd3293-65020 https://curecurrent.com/trials/progression-delaying-effect-of-escitalopram-in-alzheimer-s-disease-65021 https://curecurrent.com/trials/safety-of-switching-from-donepezil-to-rivastigmine-patch-in-patients-with-probable-alzheimer-s-disease-65022 https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-and-blood-levels-of-pf-03654746-in-subjects-with-mild-to-moderate-alzheimer-65023 https://curecurrent.com/trials/research-involving-subjects-with-parkinson-s-disease-alzheimer-disease-and-healthy-controls-65024 https://curecurrent.com/trials/phase-1-and-phase-2-clinical-trials-of-snubh-nm-333-18f-65025 https://curecurrent.com/trials/an-observational-study-of-the-safety-and-effectiveness-of-galantamine-in-the-treatment-of-patients-with-alzheimer-s-dise-65026 https://curecurrent.com/trials/effects-of-sleep-deprivation-on-cerebrospinal-fluid-csf-amyloid-beta-a-dynamics-65027 https://curecurrent.com/trials/cilostazol-augmentation-study-in-dementia-65028 https://curecurrent.com/trials/amyloid-imaging-and-safety-study-of-subcutaneous-bapineuzumab-in-subjects-with-mild-to-moderate-alzheimer-s-disease-65029 https://curecurrent.com/trials/evaluation-of-123-i-iodobenzovesamicol-ibvm-and-spect-imaging-of-healthy-subjects-and-patients-with-alzheimer-disease-65030 https://curecurrent.com/trials/study-of-octagam-intravenous-immunoglobulin-ivig-10-on-the-treatment-of-mild-to-moderate-alzheimer-s-disease-65031 https://curecurrent.com/trials/the-circadian-study-evaluation-of-modulating-effect-of-galantamine-on-circadian-rhythm-in-patients-with-mild-to-moderate-65032 https://curecurrent.com/trials/safety-and-cognitive-function-study-of-evp-6124-in-patients-with-mild-to-moderate-alzheimer-s-disease-65033 https://curecurrent.com/trials/safety-and-tolerability-of-etanercept-in-alzheimer-s-disease-65034 https://curecurrent.com/trials/cerebrospinal-fluid-csf-biomarkers-alzheimer-s-disease-ad-and-non-ad-dementias-65035 https://curecurrent.com/trials/effects-of-exercise-training-in-patients-with-mild-cognitive-impairment-65036 https://curecurrent.com/trials/effect-of-neuroad-on-alzheimer-patients-65037 https://curecurrent.com/trials/effects-of-exercise-training-in-patients-with-mild-cognitive-impairment-and-early-alzheimer-s-disease-65038 https://curecurrent.com/trials/an-efficacy-and-safety-study-of-galantamine-for-the-treatment-of-patients-with-alzheimer-s-disease-65039 https://curecurrent.com/trials/prism-registry-pseudobulbar-affect-registry-series-65040 https://curecurrent.com/trials/a-study-to-examine-the-distribution-of-pf-05212377-in-the-brain-of-healthy-volunteer-subjects-using-positron-emission-to-65041 https://curecurrent.com/trials/yogic-breathing-changes-salivary-components-65042 https://curecurrent.com/trials/prospective-memory-imaging-65043 https://curecurrent.com/trials/imaging-of-new-learning-in-severe-alzheimer-s-disease-patients-65044 https://curecurrent.com/trials/a-two-part-multiple-dose-study-to-assess-the-safety-and-effects-of-azd3293-in-healthy-elderly-and-alzheimer-s-patients-65045 https://curecurrent.com/trials/evaluation-of-efficacy-and-safety-of-galantamine-in-patients-with-dementia-of-alzheimer-s-type-who-failed-to-benefit-fro-65046 https://curecurrent.com/trials/inappropriate-medications-associated-with-anticholinesterase-and-or-memantine-treatment-in-the-elderly-65047 https://curecurrent.com/trials/a-study-to-measure-csf-proteins-in-elderly-healthy-volunteers-and-volunteers-with-mild-cognitive-impairment-or-alzheimer-65048 https://curecurrent.com/trials/efficacy-of-pulsatile-iv-insulin-on-cognition-and-amyloid-burden-in-patients-with-alzheimer-s-disease-65049 https://curecurrent.com/trials/observational-study-of-donepezil-in-routine-clinical-practice-65050 https://curecurrent.com/trials/treating-behavioral-disturbances-in-individuals-with-dementia-65051 https://curecurrent.com/trials/evaluation-of-a-handheld-event-related-potential-erp-quantitative-electroencephalography-qeeg-system-cognision-as-a-usef-65052 https://curecurrent.com/trials/assess-123-i-impy-and-spect-imaging-as-a-tool-to-detect-amyloid-in-the-brain-65053 https://curecurrent.com/trials/treatment-for-early-memory-loss-65054 https://curecurrent.com/trials/effect-of-exercises-training-in-patients-with-mild-cognitive-impairment-and-early-alzheimer-s-disease-65055 https://curecurrent.com/trials/the-study-of-microrna-107-mirna-107-and-beta-amyloid-precursor-protein-cleaving-enzyme-1-bace1-messenger-ribonucleic-aci-65056 https://curecurrent.com/trials/genes-exercise-memory-and-neurodegeneration-65057 https://curecurrent.com/trials/a-pilot-trial-of-interferon-beta-1a-in-alzheimer-s-disease-65058 https://curecurrent.com/trials/efficacy-and-safety-of-rivastigmine-transdermal-patch-in-patients-with-mild-to-moderate-alzheimer-s-disease-65059 https://curecurrent.com/trials/evaluation-of-safety-tolerability-of-multiple-dose-regimens-of-chf-5074-and-exploration-of-effects-on-potential-markers-65060 https://curecurrent.com/trials/evaluation-of-safety-tolerability-of-multiple-dose-regimens-of-chf-5074-and-exploration-of-effects-on-potential-markers-65061 https://curecurrent.com/trials/measurement-of-retinal-nerve-fiber-layer-thickness-a-biomarker-for-the-early-detection-of-alzheimer-s-disease-65062 https://curecurrent.com/trials/magnetic-resonance-spectroscopy-study-of-memantine-in-alzheimer-s-disease-65063 https://curecurrent.com/trials/effect-of-repetitive-transcranial-magnetic-stimulation-on-language-in-alzheimer-s-disease-65064 https://curecurrent.com/trials/effectiveness-of-an-electronic-training-program-for-orienting-and-interpreting-18f-flutemetamol-positron-emission-tomogr-65065 https://curecurrent.com/trials/nutritional-programme-for-dementia-elderly-patient-65066 https://curecurrent.com/trials/delta-thc-in-behavioral-disturbances-in-dementia-65067 https://curecurrent.com/trials/the-detection-of-early-dementia-with-the-digital-game-memory-65068 https://curecurrent.com/trials/new-proteins-in-body-fluids-as-potential-biomarker-for-alzheimer-s-disease-a-pilot-study-65069 https://curecurrent.com/trials/a-study-to-investigate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-jnj-54861911-in-healthy-elderly-65070 https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-of-evp-0962-and-effects-of-evp-0962-on-cerebral-spinal-fluid-amyloid-concentrations-65071 https://curecurrent.com/trials/efficacy-of-early-stage-alzheimer-s-support-groups-65072 https://curecurrent.com/trials/effects-of-transcranial-direct-current-stimulation-on-the-apathy-of-alzheimer-s-disease-65073 https://curecurrent.com/trials/a-long-term-safety-and-tolerability-study-of-bapineuzumab-in-alzheimer-disease-patients-65074 https://curecurrent.com/trials/blood-brain-barrier-leakage-in-dementia-a-dynamic-contrast-enhanced-mri-study-65075 https://curecurrent.com/trials/a-long-term-safety-and-tolerability-study-in-subjects-with-mild-to-moderate-alzheimer-s-disease-65076 https://curecurrent.com/trials/smart-somatotrophics-memory-and-aging-research-trial-65077 https://curecurrent.com/trials/cognitive-behavioural-therapy-for-persons-with-mci-or-mild-dementia-65078 https://curecurrent.com/trials/positron-emission-tomography-imaging-of-brain-amyloid-in-normal-pressure-hydrocephalus-65079 https://curecurrent.com/trials/clinical-and-immunological-activity-safety-and-tolerability-of-different-doses-formulations-of-affitope-ad02-in-early-al-65080 https://curecurrent.com/trials/observational-follow-up-extension-study-of-aff002-and-aff004a-in-patients-with-alzheimer-s-disease-65081 https://curecurrent.com/trials/vi-1121-for-the-treatment-alzheimer-s-disease-65082 https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-abt-354-in-subjects-with-mild-to-moderate-alzheimer-s-disease-on-stable-dose-65083 https://curecurrent.com/trials/blood-brain-barrier-permeability-in-alzheimer-s-disease-65084 https://curecurrent.com/trials/usability-study-of-spaced-retrieval-exercise-using-mobile-devices-for-alzheimer-s-disease-rehabilitation-65085 https://curecurrent.com/trials/efficacy-and-safety-of-memantine-in-moderate-to-severe-alzheimer-s-disease-65086 https://curecurrent.com/trials/positron-emission-tomography-pet-imaging-of-brain-amyloid-compared-to-post-mortem-levels-65087 https://curecurrent.com/trials/impact-of-a-memory-group-for-older-adults-reporting-memory-difficulties-65088 https://curecurrent.com/trials/aripiprazole-in-the-treatment-of-patients-with-psychosis-associated-with-dementia-of-alzheimer-s-type-65089 https://curecurrent.com/trials/multiple-nutritional-deficiencies-causing-dementia-of-the-alzheimer-type-65090 https://curecurrent.com/trials/a-confirmatory-trial-of-sk-pc-b70m-in-mild-to-moderate-alzheimer-s-disease-65091 https://curecurrent.com/trials/construction-lbd-constructional-apraxia-in-alzheimer-s-disease-ad-and-lewy-body-s-dementia-lbd-65092 https://curecurrent.com/trials/aab-001-bapineuzumab-open-label-long-term-extension-study-in-patients-with-mild-to-moderate-alzheimer-s-disease-65093 https://curecurrent.com/trials/bapineuzumab-in-patients-with-mild-to-moderate-alzheimer-s-disease-apoe4-non-carrier-65094 https://curecurrent.com/trials/bapineuzumab-in-patients-with-mild-to-moderate-alzheimer-s-disease-apoe4-carrier-65095 https://curecurrent.com/trials/correlation-between-regional-brain-volume-and-response-to-donepezil-treatment-in-ad-patients-65096 https://curecurrent.com/trials/study-evaluating-bapineuzumab-in-alzheimer-disease-subjects-65097 https://curecurrent.com/trials/a-comparison-of-two-standard-therapies-in-the-management-of-dementia-with-agitation-65098 https://curecurrent.com/trials/study-of-aripiprazole-in-the-treatment-of-patients-with-psychosis-associated-with-dementia-of-the-alzheimer-s-type-65099 https://curecurrent.com/trials/intramuscular-aripiprazole-in-acutely-agitated-patients-diagnosed-with-dementia-65100 https://curecurrent.com/trials/evaluation-of-18f-pbr111-and-pet-as-a-marker-of-inflammation-in-subjects-with-neurological-conditions-65101 https://curecurrent.com/trials/study-of-aripiprazole-in-the-treatment-of-patients-with-psychosis-associated-with-dementia-of-the-alzheimer-s-type-65102 https://curecurrent.com/trials/evaluation-of-18f-fmh3-and-pet-as-a-marker-of-histamine-3-receptor-activity-in-subjects-with-ad-compared-w-hc-65103 https://curecurrent.com/trials/follow-up-study-to-evaluate-long-term-safety-and-tolerability-of-immunization-with-ad03-applied-during-aff005a-65104 https://curecurrent.com/trials/efficacy-and-safety-of-t-817ma-in-patients-with-mild-to-moderate-alzheimer-s-disease-65105 https://curecurrent.com/trials/an-evaluation-of-three-doses-of-ns-2330-in-patients-with-mild-to-moderate-dementia-of-the-alzheimer-s-type-65106 https://curecurrent.com/trials/internet-app-to-self-manage-occasional-low-back-pain-65107 https://curecurrent.com/trials/alzheimer-s-family-research-65108 https://curecurrent.com/trials/a-monocenter-cross-sectional-study-to-compare-different-type-of-cognitive-impairment-in-multiple-sclerosis-patients-and-65109 https://curecurrent.com/trials/a-phase-ii-trial-of-florbetapir-18f-positron-emission-tomography-pet-imaging-in-japan-of-healthy-volunteers-patients-wit-65110 https://curecurrent.com/trials/a-study-of-galantamine-used-to-treat-patients-with-mild-to-moderate-alzheimer-s-disease-65111 https://curecurrent.com/trials/a-study-of-florbetapir-18f-in-japanese-healthy-volunteers-65112 https://curecurrent.com/trials/effects-of-exercise-and-cognitive-training-on-cognitive-function-in-older-adults-65113 https://curecurrent.com/trials/zydena-on-cognitive-function-of-alzheimer-s-disease-patients-65114 https://curecurrent.com/trials/acute-effects-of-donepezil-on-brain-perfusion-and-memory-in-subjects-with-cognitive-impairment-and-mild-alzheimer-s-dise-65115 https://curecurrent.com/trials/multiple-ascending-dose-study-of-tc-5619-in-healthy-elderly-subjects-and-subjects-with-alzheimer-s-disease-65116 https://curecurrent.com/trials/evaluation-of-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-e2609-in-healthy-subjects-and-an-elderly-65117 https://curecurrent.com/trials/effects-of-rivastigmine-patch-on-activities-of-daily-living-and-cognition-in-patients-with-severe-dementia-of-the-alzhei-65118 https://curecurrent.com/trials/the-efficacy-of-a-combination-regimen-in-patients-with-mild-to-moderate-probable-alzheimer-s-disease-65119 https://curecurrent.com/trials/a-study-to-show-that-the-change-of-attention-measure-is-correlated-with-the-changes-of-caregiver-s-burden-after-treatmen-65120 https://curecurrent.com/trials/evaluation-of-the-neuroinflammation-pattern-of-bay85-8102-f-18-dpa-714-in-probable-alzheimers-disease-patients-versus-he-65121 https://curecurrent.com/trials/a-phase-0-open-label-multi-center-exploratory-and-safety-study-of-f-18-t807-65122 https://curecurrent.com/trials/a-phase-0-open-label-multi-center-exploratory-and-safety-study-of-f-18-t808-65123 https://curecurrent.com/trials/multistimulation-group-therapy-for-alzheimer-s-disease-65124 https://curecurrent.com/trials/positron-emission-tomography-pet-amyloid-imaging-of-the-brain-in-healthy-young-adult-subjects-65125 https://curecurrent.com/trials/safety-and-efficacy-study-of-ac-3933-in-adults-with-mild-to-moderate-alzheimer-s-disease-65126 https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-for-apathy-treatment-in-alzheimer-s-disease-65127 https://curecurrent.com/trials/alpha-synuclein-in-cerebrospinal-fluid-to-differentiate-alzheimer-s-disease-from-lewy-body-disease-65128 https://curecurrent.com/trials/biomarker-study-to-diagnose-alzheimer-s-disease-65129 https://curecurrent.com/trials/amyloid-accumulation-after-mild-traumatic-brain-injury-65130 https://curecurrent.com/trials/deep-brain-stimulation-dbs-of-the-nucleus-basalis-meynert-nbm-to-treat-cognitive-deficits-in-light-to-moderate-alzheimer-65131 https://curecurrent.com/trials/nmda-enhancing-agent-for-treatment-of-mild-cognitive-impairment-and-mild-alzheimer-s-disease-65132 https://curecurrent.com/trials/mirtazapine-for-sleep-disorders-in-alzheimer-s-disease-65133 https://curecurrent.com/trials/study-of-the-effects-of-cerefolin-nac-on-inflammation-blood-markers-in-older-individuals-with-memory-complaints-65134 https://curecurrent.com/trials/a-randomized-double-blind-placebo-controlled-sequential-ascending-single-dose-study-to-evaluate-the-safety-tolerability-65135 https://curecurrent.com/trials/an-study-to-determine-the-bioavailability-of-e2609-tablets-compared-to-capsules-and-the-effect-of-food-on-absorption-65136 https://curecurrent.com/trials/computer-based-training-for-mild-alzheimer-s-disease-65137 https://curecurrent.com/trials/nac-003-p-l-u-s-program-progress-through-learning-understanding-support-65138 https://curecurrent.com/trials/antipsychotic-discontinuation-in-alzheimer-s-disease-65139 https://curecurrent.com/trials/identifying-potential-effects-of-liraglutide-on-degenerative-changes-65140 https://curecurrent.com/trials/a-survey-study-of-the-treatment-and-outcome-management-in-patients-diagnosed-with-alzheimer-s-disease-65141 https://curecurrent.com/trials/functional-brain-imaging-of-medication-treatment-response-in-mild-alzheimer-s-disease-patients-65142 https://curecurrent.com/trials/pregnenolone-sulfate-an-early-marker-of-the-memory-loss-in-alzheimer-s-disease-65143 https://curecurrent.com/trials/a-study-to-evaluate-the-abuse-potential-of-single-oral-doses-of-dimebon-latrepirdine-in-healthy-recreational-polydrug-us-65144 https://curecurrent.com/trials/safety-and-tolerability-study-in-patients-with-mild-to-moderate-alzheimer-s-disease-ad-65145 https://curecurrent.com/trials/observational-study-of-cognitive-outcomes-for-subjects-who-have-had-prior-pet-amyloid-imaging-with-florbetapir-f-18-18f-65146 https://curecurrent.com/trials/tms-stimulation-and-cognitive-training-in-alzheimer-patients-65147 https://curecurrent.com/trials/ginkgo-biloba-prevention-trial-in-older-individuals-65148 https://curecurrent.com/trials/multi-modal-neuroimaging-in-alzheimer-s-disease-65149 https://curecurrent.com/trials/icare-stress-management-e-training-for-dementia-family-caregivers-65150 https://curecurrent.com/trials/memantine-and-validation-of-a-new-alzheimer-s-disease-scale-65151 https://curecurrent.com/trials/the-prevalence-of-vitamin-d-deficiency-in-patients-with-alzheimer-s-disease-65152 https://curecurrent.com/trials/antidepressant-medication-plus-donepezil-for-treating-late-life-depression-65153 https://curecurrent.com/trials/efficacy-and-safety-of-lornoxicam-in-patients-with-mild-to-moderate-probable-alzheimer-s-disease-65154 https://curecurrent.com/trials/relationship-between-vestibular-function-and-topographic-memory-65155 https://curecurrent.com/trials/efficacy-and-safety-study-for-subjects-with-mild-to-moderate-alzheimer-s-disease-65156 https://curecurrent.com/trials/study-comparing-3-dosage-levels-of-sam-531-in-outpatients-with-mild-to-moderate-alzheimer-disease-65157 https://curecurrent.com/trials/to-compare-positron-emission-tomography-pet-measurements-of-fibrillar-amyloid-burden-65158 https://curecurrent.com/trials/efficacy-and-safety-study-of-abt-384-in-subjects-with-mild-to-moderate-alzheimer-s-disease-65159 https://curecurrent.com/trials/use-of-different-treatment-care-methods-in-patients-with-dementia-associated-with-alzheimer-s-disease-65160 https://curecurrent.com/trials/memantine-on-aggression-and-agitation-of-alzheimer-s-disease-ad-65161 https://curecurrent.com/trials/evaluation-of-the-diagnostic-potential-of-bay1006578-in-probable-alzheimers-disease-patients-versus-healthy-volunteers-a-65162 https://curecurrent.com/trials/effects-of-rosiglitazone-extended-release-tablets-on-cerebral-glucose-utilisation-and-cognition-alzheimers-disease-65163 https://curecurrent.com/trials/efficacy-and-safety-of-filgrastim-in-alzheimer-s-disease-65164 https://curecurrent.com/trials/the-efficacy-of-galantamine-treatment-on-attention-in-patients-with-alzheimer-s-disease-65165 https://curecurrent.com/trials/ecological-assessment-of-apathy-in-alzheimer-s-disease-and-in-control-subjects-video-recognition-and-actigraphy-65166 https://curecurrent.com/trials/study-of-nasal-insulin-to-fight-forgetfulness-long-acting-insulin-detemir-21-days-65167 https://curecurrent.com/trials/therapeutic-effect-of-direct-current-stimulation-on-cognitive-function-of-mild-to-moderate-alzheimer-patients-65168 https://curecurrent.com/trials/safety-and-efficacy-study-of-fx-1006a-in-patients-with-familial-amyloidosis-65169 https://curecurrent.com/trials/an-extension-of-study-fx-005-evaluating-long-term-safety-and-clinical-outcomes-of-fx-1006a-in-patients-with-transthyreti-65170 https://curecurrent.com/trials/effect-of-ly2062430-on-the-progression-of-alzheimer-s-disease-65171 https://curecurrent.com/trials/an-open-positron-emission-tomography-study-to-assess-the-effects-of-varying-mass-of-azd4694-on-radioligand-binding-param-65172 https://curecurrent.com/trials/evaluating-the-impact-of-donepezil-hydrochloride-aricept-on-behavioral-and-psychological-symptoms-in-patients-with-sever-65173 https://curecurrent.com/trials/ac-1204-long-term-efficacy-response-trial-alert-protocol-65174 https://curecurrent.com/trials/randomized-trial-of-a-nutritional-supplement-in-alzheimer-s-disease-65175 https://curecurrent.com/trials/an-extension-to-the-b1451027-protocol-to-evaluate-the-long-term-safety-and-tolerability-of-dimebon-in-patients-with-alzh-65176 https://curecurrent.com/trials/the-effect-of-jnj-39393406-on-event-related-potentials-in-stable-schizophrenic-patients-65177 https://curecurrent.com/trials/a-study-to-evaluate-sleep-quality-in-patients-with-mild-to-moderate-alzheimer-s-disease-65178 https://curecurrent.com/trials/trazodone-for-sleep-disorders-in-alzheimer-s-disease-65179 https://curecurrent.com/trials/effects-of-delivery-mode-of-cognition-intervention-in-early-alzheimer-s-disease-65180 https://curecurrent.com/trials/an-extension-to-the-b1451006-protocol-to-evaluate-the-safety-and-efficacy-of-dimebon-in-subjects-with-moderate-to-severe-65181 https://curecurrent.com/trials/a-phase-3-efficacy-study-of-dimebon-in-patients-with-moderate-to-severe-alzheimer-s-disease-65182 https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-tideglusib-to-treat-mild-to-moderate-alzheimer-s-disease-patients-65183 https://curecurrent.com/trials/the-long-term-safety-and-efficacy-follow-up-study-of-subjects-who-completed-the-phase-i-clinical-trial-of-neurostem-ad-65184 https://curecurrent.com/trials/efficacy-and-tolerability-of-mlc601-in-patients-with-mild-to-moderate-alzheimer-disease-who-were-unable-to-tolerate-or-f-65185 https://curecurrent.com/trials/randomized-trial-of-exercise-and-social-interaction-in-a-community-based-sample-of-non-demented-chinese-elders-65186 https://curecurrent.com/trials/clinical-research-center-for-dementia-of-south-korea-credos-or-crcd-65187 https://curecurrent.com/trials/phase-ii-study-for-amyloid-binding-imaging-study-of-18f-av-45-in-patients-with-mild-cognitive-impairment-alzheimer-s-dis-65188 https://curecurrent.com/trials/effect-of-pf-04360365-on-abeta-in-patients-with-alzheimer-s-disease-and-healthy-volunteers-65189 https://curecurrent.com/trials/a-biomarker-study-of-solanezumab-in-patients-with-and-without-alzheimer-s-65190 https://curecurrent.com/trials/effect-of-ly2062430-on-the-progression-of-alzheimer-s-disease-65191 https://curecurrent.com/trials/comparative-efficacy-safety-and-tolerability-of-rivastigmine-10-and-15-cm-2-patch-in-patients-with-alzheimer-s-disease-a-65192 https://curecurrent.com/trials/sniff-120-study-of-nasal-insulin-to-fight-forgetfulness-120-days-65193 https://curecurrent.com/trials/non-expensive-and-widely-available-tests-as-diagnostic-tools-in-dementia-and-their-ability-to-predict-disease-progressio-65194 https://curecurrent.com/trials/a-clinical-study-evaluating-the-effects-of-memantine-on-brain-atrophy-in-patients-with-alzheimer-s-disease-65195 https://curecurrent.com/trials/safety-study-of-hpp854-in-subjects-with-mild-cognitive-impairment-or-a-diagnosis-of-mild-alzheimer-s-disease-65196 https://curecurrent.com/trials/safety-and-tolerability-of-memantine-in-moderate-to-severe-alzheimer-s-disease-65197 https://curecurrent.com/trials/exploratory-and-safety-study-of-f-18-w372-65198 https://curecurrent.com/trials/a-trial-of-18f-av-133-and-18f-av-45-positron-emission-tomography-pet-65199 https://curecurrent.com/trials/video-based-coping-skills-training-for-caregivers-65200 https://curecurrent.com/trials/thalidomide-for-patients-with-mild-to-moderate-alzheimer-s-disease-65201 https://curecurrent.com/trials/alzheimer-s-in-long-term-care-treatment-for-agitation-65202 https://curecurrent.com/trials/ability-of-18f-av-45-pet-scan-to-distinguish-alzheimer-s-disease-subjects-from-cognitively-normal-individuals-65203 https://curecurrent.com/trials/performance-of-aclarusdx-a-blood-based-transcriptomic-test-for-ad-in-us-patients-newly-referred-to-a-memory-center-65204 https://curecurrent.com/trials/chronic-electrical-stimulation-of-hypothalamus-fornix-in-alzheimer-s-disease-65205 https://curecurrent.com/trials/ubiquitous-spaced-retrieval-based-memory-advancement-and-rehabilitation-training-65206 https://curecurrent.com/trials/evaluation-of-a-diet-in-patients-with-senile-dementia-65207 https://curecurrent.com/trials/establish-taiwan-alzheimer-s-disease-neuroimaging-initiative-a-three-year-pilot-study-65208 https://curecurrent.com/trials/a-study-of-two-doses-of-18f-av-45-in-alzheimer-s-disease-and-healthy-volunteers-65209 https://curecurrent.com/trials/the-clinical-study-of-pitavastatin-treatment-for-group-of-mild-to-moderate-alzheimer-s-disease-65210 https://curecurrent.com/trials/behavioral-sleep-intervention-in-adult-family-homes-65211 https://curecurrent.com/trials/effects-of-ono-2506po-in-patients-with-alzheimer-s-disease-65212 https://curecurrent.com/trials/pet-imaging-of-brain-amyloid-in-normal-pressure-hydrocephalus-65213 https://curecurrent.com/trials/evaluation-of-physician-training-methods-to-read-florbetapir-pet-scans-65214 https://curecurrent.com/trials/a-randomized-study-to-evaluate-fk962-in-subjects-with-mild-to-moderate-alzheimer-s-disease-65215 https://curecurrent.com/trials/evaluation-of-web-based-training-to-educate-physicians-in-the-methods-of-interpreting-florbetapir-pet-scans-65216 https://curecurrent.com/trials/preliminary-efficacy-and-safety-study-of-st101-plus-aricept-in-alzheimer-s-disease-65217 https://curecurrent.com/trials/preliminary-efficacy-and-safety-study-of-st101-in-alzheimer-s-disease-65218 https://curecurrent.com/trials/evaluation-of-pet-scan-timing-relative-to-av-45-injection-time-65219 https://curecurrent.com/trials/mindfulness-based-stress-reduction-for-adults-with-mild-cognitive-impairment-65220 https://curecurrent.com/trials/phase-iii-study-of-the-correlation-between-florbetapir-f18-pet-imaging-and-amyloid-pathology-in-the-brain-65221 https://curecurrent.com/trials/a-preliminary-study-of-18f-av-45-in-alzheimer-s-disease-and-healthy-elderly-volunteers-65222 https://curecurrent.com/trials/a-study-of-18f-av-45-in-healthy-volunteers-65223 https://curecurrent.com/trials/a-study-of-18f-av-45-in-alzheimer-s-disease-ad-and-healthy-volunteers-65224 https://curecurrent.com/trials/a-phase-ii-trial-of-18f-av-45-positron-emission-tomography-pet-imaging-in-healthy-volunteers-patients-with-mild-cognitiv-65225 https://curecurrent.com/trials/enhancing-quality-of-life-for-nursing-home-residents-65226 https://curecurrent.com/trials/safety-study-of-passive-immunization-for-patients-with-mild-to-moderate-alzheimer-s-disease-65227 https://curecurrent.com/trials/multicenter-vitamin-e-trial-in-aging-persons-with-down-syndrome-65228 https://curecurrent.com/trials/vitamin-e-in-aging-persons-with-down-syndrome-65229 https://curecurrent.com/trials/a-phase-1-study-of-the-safety-tolerability-and-pharmacokinetics-of-abt-126-in-subjects-with-alzheimer-s-disease-65230 https://curecurrent.com/trials/evaluation-of-alteration-by-magnetic-resonance-imaging-mri-in-dementia-among-elderly-subjects-65231 https://curecurrent.com/trials/the-safety-and-the-efficacy-evaluation-of-neurostem-ad-in-patients-with-alzheimer-s-disease-65232 https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetic-study-of-evp-6124-in-patients-with-alzheimer-s-disease-65233 https://curecurrent.com/trials/clinical-effectiveness-of-10-cm-2-rivastigmine-patch-in-patients-with-alzheimer-s-disease-65234 https://curecurrent.com/trials/an-observational-study-for-analysis-of-mortality-in-participants-who-participated-in-previous-3-studies-of-galantamine-65235 https://curecurrent.com/trials/study-of-octohydroaminoacridine-succinate-tablets-in-patients-with-alzheimer-s-disease-65236 https://curecurrent.com/trials/assessment-of-safety-tolerability-and-blood-concentrations-of-single-doses-of-azd3839-in-healthy-volunteers-65237 https://curecurrent.com/trials/memory-disorders-registry-65238 https://curecurrent.com/trials/comparison-of-3-learning-methods-to-improve-independent-activities-of-daily-living-iadls-in-alzheimer-disease-65239 https://curecurrent.com/trials/non-pharmacological-management-of-behavioural-symptoms-in-nursing-home-65240 https://curecurrent.com/trials/truncated-and-extended-forms-of-amyloid-beta-peptides-in-alzheimer-s-disease-genesis-toxicity-and-identification-as-biol-65241 https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-galantamine-hydrobromide-in-patients-with-alzheimer-s-disease-65242 https://curecurrent.com/trials/effects-of-exercise-and-rivastigmine-on-quality-of-life-of-alzheimer-s-disease-patients-65243 https://curecurrent.com/trials/aab-001-in-patients-with-mild-to-moderate-alzheimer-s-disease-65244 https://curecurrent.com/trials/predictive-value-of-cognitive-tests-performed-for-the-diagnosis-of-alzheimer-s-disease-and-related-disorders-65245 https://curecurrent.com/trials/self-care-talk-study-promoting-alzheimer-s-disease-ad-spousal-caregiver-health-65246 https://curecurrent.com/trials/the-safety-and-efficacy-of-neramexane-in-patients-with-moderate-to-severe-alzheimer-s-disease-65247 https://curecurrent.com/trials/an-evaluation-of-the-safety-and-efficacy-of-memantine-in-agitated-patients-with-moderate-to-severe-alzheimer-s-disease-65248 https://curecurrent.com/trials/escitalopram-treatment-of-patients-with-agitated-dementia-65249 https://curecurrent.com/trials/evaluation-of-18f-feppa-and-pet-imaging-as-a-marker-of-inflammation-in-subjects-with-neurological-conditions-65250 https://curecurrent.com/trials/using-behavioral-programs-to-treat-sleep-problems-in-individuals-with-alzheimer-s-disease-65251 https://curecurrent.com/trials/follow-up-study-of-the-alzheimer-s-disease-anti-inflammatory-prevention-trial-65252 https://curecurrent.com/trials/mirtazapine-in-alzheimer-associated-weight-loss-65253 https://curecurrent.com/trials/lu-ae58054-added-to-donepezil-for-the-treatment-for-moderate-alzheimer-s-disease-65254 https://curecurrent.com/trials/safety-and-tolerability-of-affitope-ad03-65255 https://curecurrent.com/trials/evaluation-of-apathy-using-attentional-reaction-test-in-neurodegenerative-diseases-65256 https://curecurrent.com/trials/eeg-objectification-in-neuropsychiatry-65257 https://curecurrent.com/trials/evaluation-of-the-efficacy-of-varenicline-on-cognition-safety-tolerability-and-pharmacokinetics-in-subjects-with-mild-to-65258 https://curecurrent.com/trials/study-to-evaluate-the-safety-pharmacokinetics-and-tolerability-of-bms-708163-65259 https://curecurrent.com/trials/rivastigmine-monotherapy-and-combination-therapy-with-memantine-in-patients-with-moderately-severe-alzheimer-s-disease-w-65260 https://curecurrent.com/trials/the-dementia-study-in-northern-norway-65261 https://curecurrent.com/trials/memantine-communication-study-65262 https://curecurrent.com/trials/life-from-vision-in-alzheimer-disease-65263 https://curecurrent.com/trials/study-of-social-behavior-and-emotion-in-frontotemporal-dementia-alzheimer-s-disease-and-controls-65264 https://curecurrent.com/trials/rivastigmine-in-mild-alzheimer-s-disease-fmri-study-65265 https://curecurrent.com/trials/the-occurrence-of-the-apoe4-allele-in-agitated-in-patients-with-late-onset-alzheimer-s-disease-65266 https://curecurrent.com/trials/neptune-krill-oil-nko-in-early-stage-alzheimer-s-disease-mnemosyne-65267 https://curecurrent.com/trials/functional-magnetic-resonance-imaging-fmri-of-anosognosia-in-amnestic-mild-cognitive-impairment-mci-and-alzheimer-s-dise-65268 https://curecurrent.com/trials/memantine-and-antipsychotics-use-65269 https://curecurrent.com/trials/psychopathological-risk-factors-associated-with-conversion-from-mild-cognitive-impairment-to-dementia-65270 https://curecurrent.com/trials/deep-transcranial-magnetic-stimulation-in-patients-with-alzheimer-s-disease-65271 https://curecurrent.com/trials/early-detection-of-mild-cognitive-impairment-in-individual-patients-65272 https://curecurrent.com/trials/a-study-of-the-long-term-safety-of-abt-089-for-subjects-with-mild-to-moderate-alzheimer-s-disease-who-participated-in-th-65273 https://curecurrent.com/trials/study-to-evaluate-safety-tolerability-and-immunogenicity-of-vaccine-ub-311-in-subjects-with-alzheimer-s-disease-65274 https://curecurrent.com/trials/safety-and-efficacy-study-of-abt-089-in-adults-with-mild-to-moderate-alzheimer-s-disease-65275 https://curecurrent.com/trials/telephone-call-from-acute-care-physicians-to-long-term-care-physicians-impact-on-transitional-care-of-elderly-patients-65276 https://curecurrent.com/trials/multiple-intravenous-dose-study-of-pf-04360365-in-japanese-patients-with-mild-to-moderate-alzheimer-s-disease-65277 https://curecurrent.com/trials/rosiglitazone-effects-on-cognition-for-adults-in-later-life-65278 https://curecurrent.com/trials/innovative-biomarkers-in-alzheimer-s-disease-and-frontotemporal-dementia-ftd-preventative-and-personalized-65279 https://curecurrent.com/trials/a-24-week-multicenter-open-evaluation-of-the-clinical-effectiveness-of-the-once-daily-10-cm-2-rivastigmine-patch-formula-65280 https://curecurrent.com/trials/safety-and-efficacy-of-positron-emission-tomography-pet-imaging-with-mni-558-65281 https://curecurrent.com/trials/efficacy-and-safety-of-tamibarotene-oam80-for-alzheimer-s-disease-65282 https://curecurrent.com/trials/observational-study-to-monitor-long-term-immunogenicity-and-efficacy-of-ub-311-vaccine-in-subjects-with-alzheimer-s-dise-65283 https://curecurrent.com/trials/safety-and-efficacy-study-of-magnetic-fields-to-treat-alzheimer-s-disease-65284 https://curecurrent.com/trials/study-of-the-role-of-g72-in-amyotrophic-lateral-sclerosis-biomarker-discovery-and-mechanism-investigation-65285 https://curecurrent.com/trials/treatment-of-severe-alzheimer-s-disease-evaluation-of-efficacy-and-safety-of-galantamine-hydrobromide-in-a-controlled-st-65286 https://curecurrent.com/trials/an-efficacy-and-safety-study-of-inm-176-for-the-treatment-of-patients-with-alzheimer-type-dementia-65287 https://curecurrent.com/trials/a-study-of-the-effects-on-sleep-attention-and-gastrointestinal-tolerance-of-galantamine-and-donepezil-in-patients-with-a-65288 https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-galantamine-in-patients-with-mild-cognitive-impairment-65289 https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-galantamine-in-patients-with-mild-cognitive-impairment-65290 https://curecurrent.com/trials/escitalopram-and-depression-in-elderly-alzheimer-s-patients-65291 https://curecurrent.com/trials/non-pharmacological-treatment-in-alzheimer-s-disease-and-associated-disorders-65292 https://curecurrent.com/trials/study-of-magnetic-fields-to-treat-alzheimer-s-disease-65293 https://curecurrent.com/trials/a-study-of-the-effectiveness-and-safety-of-risperidone-versus-placebo-in-the-treatment-of-patients-with-hallucinations-a-65294 https://curecurrent.com/trials/placebo-controlled-evaluation-of-galantamine-in-the-treatment-of-alzheimer-s-disease-safety-and-efficacy-of-a-controlled-65295 https://curecurrent.com/trials/safety-and-tolerability-study-of-extended-release-er-galantamine-in-alzheimer-s-disease-65296 https://curecurrent.com/trials/a-randomized-double-blind-flexible-dose-multicenter-study-to-evaluate-the-effectiveness-and-safety-of-galantamine-ir-in-65297 https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-two-doses-of-galantamine-versus-placebo-in-the-treatment-of-patients-with-alz-65298 https://curecurrent.com/trials/a-cardiac-safety-study-of-galantamine-in-the-treatment-of-alzheimer-s-disease-65299 https://curecurrent.com/trials/a-follow-up-study-to-assess-safety-and-tolerability-of-galantamine-treatment-in-individuals-with-mild-cognitive-impairme-65300 https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-a-flexible-dose-of-galantamine-versus-placebo-in-the-treatment-of-patients-wi-65301 https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-galantamine-versus-placebo-in-the-treatment-of-patients-with-vascular-dementi-65302 https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-two-doses-of-galantamine-versus-placebo-in-the-treatment-of-patients-with-alz-65303 https://curecurrent.com/trials/an-efficacy-and-safety-study-of-galantamine-for-the-treatment-of-patients-with-alzheimer-s-disease-65304 https://curecurrent.com/trials/to-evaluate-effects-of-azd1446-placebo-and-donepezil-in-patients-with-alzheimer-s-disease-65305 https://curecurrent.com/trials/exercise-treatment-of-mild-stage-probable-alzheimer-s-disease-65306 https://curecurrent.com/trials/use-of-autobiographical-and-interest-assessment-for-a-better-stimulation-of-patients-in-nursing-home-65307 https://curecurrent.com/trials/quality-of-life-assessment-in-alzheimer-s-disease-ad-patients-receiving-aricept-tablets-65308 https://curecurrent.com/trials/a-phase-1-study-to-evaluate-the-pharmacokinetics-safety-and-tolerability-of-dimebon-pf-01913539-in-japanese-and-western-65309 https://curecurrent.com/trials/mri-to-measure-treatment-with-antibiotics-in-alzheimer-s-disease-65310 https://curecurrent.com/trials/computerized-personal-interventions-for-alzheimer-s-patients-65311 https://curecurrent.com/trials/effect-of-cognitive-intervention-in-alzheimer-s-disease-ad-on-functional-cortical-networks-in-fmri-65312 https://curecurrent.com/trials/study-evaluating-multiple-doses-of-gsi-953-within-the-elderly-population-65313 https://curecurrent.com/trials/study-evaluating-the-coadministration-of-begacestat-and-donepezil-65314 https://curecurrent.com/trials/earth-413-a-study-of-aricept-in-hispanic-patients-with-mild-to-moderate-alzheimer-s-disease-ad-65315 https://curecurrent.com/trials/efficacy-and-safety-of-aricept-in-the-treatment-of-severe-alzheimer-s-disease-65316 https://curecurrent.com/trials/non-interventional-study-with-aricept-evess-65317 https://curecurrent.com/trials/blood-gene-expression-signature-in-patients-diagnosed-with-probable-alzheimer-s-disease-compared-to-patients-suffering-f-65318 https://curecurrent.com/trials/convenience-tolerability-and-safety-of-change-in-the-administration-of-rivastigmine-from-capsules-to-a-transdermal-patch-65319 https://curecurrent.com/trials/a-study-of-alzheimer-s-disease-using-magnetoencephalography-meg-and-the-synchronous-neural-interaction-test-65320 https://curecurrent.com/trials/alzheimer-s-disease-and-related-disorders-65321 https://curecurrent.com/trials/an-escalating-dose-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-lnk-754-in-elderly-volunteers-and-i-65322 https://curecurrent.com/trials/study-of-adherence-and-effects-of-balance-exercices-siel-bleu-associatio-65323 https://curecurrent.com/trials/treatment-of-apathy-in-alzheimer-s-disease-with-modafinil-65324 https://curecurrent.com/trials/aidma-a-psycho-educational-program-designed-to-support-and-train-carers-of-alzheimer-s-disease-ad-patients-65325 https://curecurrent.com/trials/pharmacokinetic-comparisons-of-two-donepezil-formulations-65326 https://curecurrent.com/trials/alzheimer-s-disease-reminiscence-quality-of-life-65327 https://curecurrent.com/trials/effect-of-aricept-on-biomarkers-acetylcholine-sapp-alpha-in-cerebrospinal-fluid-65328 https://curecurrent.com/trials/the-effect-of-cognitive-function-as-measured-by-repeated-cognitive-measures-after-12-weeks-treatment-with-donepezil-65329 https://curecurrent.com/trials/study-to-evaluate-the-pharmacokinetics-safety-and-tolerability-of-bms-708163-65330 https://curecurrent.com/trials/long-term-safety-and-efficacy-of-galantamine-in-alzheimer-s-disease-65331 https://curecurrent.com/trials/efficacy-and-safety-of-risperidone-compared-with-placebo-in-the-treatment-of-psychotic-symptoms-in-patients-with-alzheim-65332 https://curecurrent.com/trials/trial-of-novel-oral-zinc-cysteine-preparation-in-alzheimer-s-disease-65333 https://curecurrent.com/trials/ad01-follow-up-extension-visit-65334 https://curecurrent.com/trials/drug-drug-interaction-to-study-the-effect-of-bms-708163-on-pharmacokinetics-pk-of-galantamine-extended-release-er-65335 https://curecurrent.com/trials/multiple-dose-japanese-bridging-study-65336 https://curecurrent.com/trials/study-of-huperzine-a-sustained-release-tablets-in-patients-with-alzheimer-s-disease-65337 https://curecurrent.com/trials/drug-drug-interaction-study-with-rifampin-65338 https://curecurrent.com/trials/drug-drug-interaction-study-with-aricept-donepezil-65339 https://curecurrent.com/trials/drug-drug-interaction-ddi-w-ketoconazole-or-fluconazole-65340 https://curecurrent.com/trials/the-efficacy-of-galantamine-on-the-attention-and-the-frontal-function-of-the-patients-with-dementia-of-alzheimer-type-65341 https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-galantamine-in-patients-with-alzheimer-s-disease-65342 https://curecurrent.com/trials/cognitive-behavioural-therapy-of-early-dementia-65343 https://curecurrent.com/trials/a-study-of-the-effectiveness-and-safety-of-risperidone-in-the-treatment-of-behavioral-disturbances-in-patients-with-deme-65344 https://curecurrent.com/trials/effect-on-the-electrocardiographic-qt-interval-corrected-for-heart-rate-qtc-in-healthy-subjects-65345 https://curecurrent.com/trials/relative-bioavailability-study-of-four-experimental-formulations-for-alzheimer-s-disease-65346 https://curecurrent.com/trials/evaluation-of-the-cognision-tm-system-as-an-event-related-potential-erp-collection-system-65347 https://curecurrent.com/trials/multiple-dose-study-of-trx0037-65348 https://curecurrent.com/trials/study-to-assess-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-azd0328-in-elderly-healthy-subjects-65349 https://curecurrent.com/trials/a-phase-i-single-dose-study-of-pf-04360365-in-japanese-patients-with-mild-to-moderate-alzheimer-s-disease-65350 https://curecurrent.com/trials/comparative-bioavailability-in-healthy-elderly-volunteers-65351 https://curecurrent.com/trials/a-study-of-the-effectiveness-and-safety-of-risperidone-versus-placebo-in-the-treatment-of-behavioral-disturbances-in-pat-65352 https://curecurrent.com/trials/memantine-and-changes-of-biological-markers-and-brain-pet-imaging-in-alzheimer-s-disease-65353 https://curecurrent.com/trials/a-study-of-the-effectiveness-and-safety-of-risperidone-in-the-treatment-of-behavioral-disturbances-in-patients-with-deme-65354 https://curecurrent.com/trials/study-of-uptake-break-down-and-elimination-of-an-investigational-drug-in-healthy-volunteers-65355 https://curecurrent.com/trials/continuous-arterial-spin-labeling-casl-mri-for-monitoring-and-prediction-of-drug-therapy-in-alzheimers-disease-ad-65356 https://curecurrent.com/trials/alzheimer-s-disease-prevention-trial-65357 https://curecurrent.com/trials/a-safety-and-tolerability-study-of-abt-126-in-elderly-65358 https://curecurrent.com/trials/a-study-of-the-safety-pharmacokinetics-pharmacodynamics-and-immunogenicity-of-anti-abeta-mabt5102a-in-patients-with-alzh-65359 https://curecurrent.com/trials/tolerability-and-safety-of-subcutaneous-administration-of-affitope-ad01-in-mild-to-moderate-alzheimer-s-disease-65360 https://curecurrent.com/trials/tolerability-and-safety-of-subcutaneous-administration-of-affitope-ad02-in-mild-to-moderate-alzheimer-s-disease-65361 https://curecurrent.com/trials/safety-tolerability-immunological-and-clinical-activity-of-a-boost-immunization-with-affitope-ad02-65362 https://curecurrent.com/trials/safety-and-efficacy-of-positron-emission-tomography-imaging-with-mni-513-65363 https://curecurrent.com/trials/evaluation-of-123i-av94-and-spect-in-subjects-with-alzheimer-disease-in-comparison-to-healthy-subjects-65364 https://curecurrent.com/trials/evaluation-of-123i-av151-and-spect-in-subjects-w-ad-in-comparison-to-healthy-subjects-65365 https://curecurrent.com/trials/a-study-of-the-safety-and-efficacy-of-memantine-in-moderate-to-severe-alzheimer-s-disease-65366 https://curecurrent.com/trials/donepezil-treatment-of-psychotic-symptoms-in-dementia-patients-65367 https://curecurrent.com/trials/project-tap-tailored-activities-project-65368 https://curecurrent.com/trials/study-evaluating-potential-interaction-between-sam-531-and-gemfibrozil-when-co-administered-65369 https://curecurrent.com/trials/effect-of-testosterone-therapy-in-men-with-alzheimer-s-disease-and-low-testosterone-65370 https://curecurrent.com/trials/improved-diagnosis-of-alzheimer-s-disease-using-magnetoencephalography-meg-65371 https://curecurrent.com/trials/improved-diagnosis-of-alzheimer-s-disease-using-the-synchronous-neural-interaction-test-65372 https://curecurrent.com/trials/4-week-safety-and-tolerability-study-in-patients-with-mild-to-moderate-alzheimer-s-disease-65373 https://curecurrent.com/trials/evolution-of-memory-related-activity-65374 https://curecurrent.com/trials/encapsulated-cell-biodelivery-of-nerve-growth-factor-to-alzheimer-s-disease-patients-65375 https://curecurrent.com/trials/effects-of-transcranial-magnetic-stimulation-tms-and-cognitive-training-for-alzheimer-patients-65376 https://curecurrent.com/trials/safety-and-feasibility-of-sodium-oxybate-in-mild-alzheimer-s-disease-patients-65377 https://curecurrent.com/trials/a-study-of-oral-pf-01913539-in-patients-with-mild-to-moderate-alzheimer-s-disease-65378 https://curecurrent.com/trials/solanezumab-safety-study-in-japanese-patients-with-alzheimer-s-disease-65379 https://curecurrent.com/trials/long-term-safety-and-tolerability-of-affitope-ad01-65380 https://curecurrent.com/trials/long-term-safety-and-tolerability-of-affitope-ad02-65381 https://curecurrent.com/trials/exelon-patch-and-combination-with-memantine-comparative-trial-65382 https://curecurrent.com/trials/safety-and-efficacy-of-high-dose-rapid-titration-galantamine-in-patients-with-alzheimer-s-disease-65383 https://curecurrent.com/trials/do-hmg-coa-reductase-inhibitors-affect-abeta-levels-65384 https://curecurrent.com/trials/study-gsi-136-in-healthy-young-and-healthy-elderly-subjects-65385 https://curecurrent.com/trials/project-cope-managing-dementia-at-home-65386 https://curecurrent.com/trials/lifezig-personalized-reminiscence-video-with-slideshows-and-music-for-individuals-with-alzheimer-s-and-dementia-65387 https://curecurrent.com/trials/study-evaluating-the-potential-interaction-between-verapamil-immediate-release-and-sam-531-when-co-administered-65388 https://curecurrent.com/trials/a-study-evaluating-the-absorption-of-dimebon-into-the-body-from-a-dimebon-solution-applied-to-the-skin-65389 https://curecurrent.com/trials/a-multi-center-randomized-double-blind-parallel-group-study-with-3-groups-receiving-placebo-5-mg-of-e2020-and-10-mg-of-e-65390 https://curecurrent.com/trials/disease-modifying-properties-of-lithium-in-the-neurobiology-of-alzheimer-s-disease-65391 https://curecurrent.com/trials/a-study-in-healthy-volunteers-to-estimate-the-pharmacokinetics-of-four-modified-release-formulations-of-dimebon-latrepir-65392 https://curecurrent.com/trials/a-phase-1-non-randomized-open-label-single-dose-study-to-evaluate-the-pharmacokinetics-safety-and-tolerability-of-dimebo-65393 https://curecurrent.com/trials/amyloid-plaque-and-tangle-imaging-in-alzheimer-s-disease-and-down-syndrome-65394 https://curecurrent.com/trials/memory-aid-for-informed-consent-in-alzheimer-s-research-65395 https://curecurrent.com/trials/glucose-metabolic-amyloid-and-tau-brain-imaging-in-down-syndrome-and-dementia-65396 https://curecurrent.com/trials/implications-of-amyloid-pathology-65397 https://curecurrent.com/trials/effect-of-memantine-on-functional-communication-in-patients-with-alzheimer-s-disease-65398 https://curecurrent.com/trials/a-dose-ranging-study-to-investigate-the-efficacy-and-safety-of-sb-742457-in-alzheimer-s-disease-65399 https://curecurrent.com/trials/predictors-of-cognitive-decline-in-normal-aging-65400 https://curecurrent.com/trials/gene-therapy-for-alzheimer-s-disease-clinical-trial-65401 https://curecurrent.com/trials/memory-impairment-study-mild-cognitive-impairment-study-65402 https://curecurrent.com/trials/antigonadotropin-leuprolide-in-alzheimer-s-disease-drug-investigation-aladdin-vp-104-study-65403 https://curecurrent.com/trials/effectiveness-of-a-nutritional-brain-metabolic-enhancer-for-alzheimer-disease-65404 https://curecurrent.com/trials/mifepristone-as-adjunctive-therapy-in-alzheimer-s-disease-65405 https://curecurrent.com/trials/alzheimer-s-disease-treatment-and-illness-perceptions-survey-tips-ii-65406 https://curecurrent.com/trials/estrogen-hormone-protocol-65407 https://curecurrent.com/trials/the-safety-and-efficacy-of-an-investigational-drug-in-delaying-the-progression-of-alzheimer-s-disease-65408 https://curecurrent.com/trials/a-multicenter-trial-of-rofecoxib-and-naproxen-in-alzheimer-s-disease-nsaid-study-65409 https://curecurrent.com/trials/sgs742-in-patients-with-mild-to-moderate-alzheimer-s-disease-ad-65410 https://curecurrent.com/trials/aladdin-study-antigonadotropin-leuprolide-in-alzheimer-s-disease-drug-investigation-65411 https://curecurrent.com/trials/a-trial-of-sk-pc-b70m-in-mild-to-moderate-alzheimer-s-disease-65412 https://curecurrent.com/trials/study-of-single-ascending-and-multiple-doses-of-pf-04447943-in-japanese-subjects-65413 https://curecurrent.com/trials/brain-uptake-and-safety-with-probable-alzheimer-s-disease-amnestic-mild-cognitive-impairment-and-healthy-volunteers-65414 https://curecurrent.com/trials/curcumin-in-patients-with-mild-to-moderate-alzheimer-s-disease-65415 https://curecurrent.com/trials/alzheimer-s-caregiver-communication-study-65416 https://curecurrent.com/trials/a-phase-i-study-to-estimate-the-effect-of-ketoconazole-and-omeprazole-on-the-pharmacokinetics-of-dimebon-in-healthy-subj-65417 https://curecurrent.com/trials/safety-study-of-a-glycogen-synthase-kinase-3-gsk3-inhibitor-in-patients-with-alzheimer-s-disease-65418 https://curecurrent.com/trials/positron-emission-tomography-pet-study-with-18f-azd4694-and-11c-azd2184-candidate-pet-ligands-for-a-amyloid-65419 https://curecurrent.com/trials/a-phase-i-single-iv-dose-of-pf-04360365-in-adults-with-mild-to-moderate-alzheimer-s-disease-65420 https://curecurrent.com/trials/effects-of-ly2062430-in-subjects-with-mild-to-moderate-alzheimer-s-disease-and-in-healthy-volunteers-65421 https://curecurrent.com/trials/study-evaluating-the-safety-tolerability-pk-and-pd-of-sam-531-in-the-subjects-with-mild-to-moderate-alzheimer-s-disease-65422 https://curecurrent.com/trials/randomized-safety-tolerability-and-pilot-efficacy-of-an-1792-in-alzheimer-s-disease-65423 https://curecurrent.com/trials/pioglitazone-in-alzheimer-disease-65424 https://curecurrent.com/trials/a-study-to-determine-the-clinical-safety-tolerability-and-exploratory-efficacy-of-eht-0202-as-adjunctive-therapy-to-acet-65425 https://curecurrent.com/trials/passport-to-brain-wellness-in-sedentary-adults-65426 https://curecurrent.com/trials/biomarkers-and-early-alzheimer-s-disease-65427 https://curecurrent.com/trials/study-evaluating-sra-333-in-mild-to-moderate-alzheimer-s-disease-ad-65428 https://curecurrent.com/trials/study-evaluating-how-quickly-and-to-what-extent-the-14-carbon-sam-531-is-absorbed-converted-eliminated-in-male-subjects-65429 https://curecurrent.com/trials/magnetic-resonance-imaging-mri-of-brain-iron-in-neurodegenerative-disease-65430 https://curecurrent.com/trials/evaluation-of-123i-mni-308-and-spect-as-a-marker-of-beta-amyloid-protein-deposition-in-ad-subjects-compared-to-hc-65431 https://curecurrent.com/trials/safety-and-effect-on-memory-of-pym50028-in-mild-alzheimer-s-disease-65432 https://curecurrent.com/trials/a-safety-and-tolerability-evaluation-of-two-10-week-dose-regimens-of-orally-administered-pf-04494700-in-alzheimer-s-pati-65433 https://curecurrent.com/trials/far-infrared-treatment-for-alzheimer-s-disease-65434 https://curecurrent.com/trials/study-evaluating-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-sam-531-in-healthy-japanese-males-65435 https://curecurrent.com/trials/study-evaluating-paz-417-in-cerebrospinal-fluid-in-subjects-with-alzheimer-s-disease-65436 https://curecurrent.com/trials/a-study-of-prx-03140-in-subjects-with-alzheimer-s-disease-receiving-a-stable-dose-of-donepezil-65437 https://curecurrent.com/trials/study-of-prx-03140-monotherapy-in-subjects-with-alzheimer-s-disease-65438 https://curecurrent.com/trials/study-evaluating-safety-tolerability-and-pharmacokinetics-of-single-and-multiple-dose-of-sam-531-65439 https://curecurrent.com/trials/cholesterol-lowering-agent-to-slow-progression-clasp-of-alzheimer-s-disease-study-65440 https://curecurrent.com/trials/single-dose-escalation-study-of-pf-04360365-in-subjects-with-mild-to-moderate-alzheimer-s-disease-65441 https://curecurrent.com/trials/risk-evaluation-and-education-for-alzheimer-s-disease-65442 https://curecurrent.com/trials/risk-evaluation-and-education-for-alzheimer-s-disease-reveal-ii-65443 https://curecurrent.com/trials/effect-on-cognitive-performance-and-safety-tolerability-of-ssr180711c-in-mild-alzheimer-s-disease-65444 https://curecurrent.com/trials/rasagiline-1-mg-and-2-mg-added-to-aricept-10-mg-daily-in-patients-with-mild-to-moderate-alzheimer-s-disease-ad-65445 https://curecurrent.com/trials/a-safety-study-of-ly2811376-single-doses-in-healthy-subjects-65446 https://curecurrent.com/trials/study-evaluating-safety-of-gsi-136-in-young-and-elderly-japanese-males-65447 https://curecurrent.com/trials/study-evaluating-paz-417-in-healthy-young-elderly-65448 https://curecurrent.com/trials/study-evaluating-the-safety-pharmacokinetics-and-pharmacodynamics-of-sam-531-65449 https://curecurrent.com/trials/drug-interaction-study-between-azd3480-and-warfarin-65450 https://curecurrent.com/trials/drug-interaction-study-between-azd3480-and-aripiprazole-in-healthy-subjects-65451 https://curecurrent.com/trials/dimebon-pf-01913539-digoxin-drug-drug-interaction-study-in-healthy-subjects-65452 https://curecurrent.com/trials/vital-vitamins-to-slow-alzheimer-s-disease-homocysteine-study-65453 https://curecurrent.com/trials/comparative-study-to-test-safety-and-efficacy-of-neurotrophic-and-cholinergic-treatment-of-alzheimer-s-disease-65454 https://curecurrent.com/trials/sb-742457-and-donepezil-in-alzheimer-s-disease-65455 https://curecurrent.com/trials/pet-changes-in-alzheimer-s-disease-ad-65456 https://curecurrent.com/trials/efficacy-study-of-mpc-7869-to-treat-patients-with-alzheimer-s-65457 https://curecurrent.com/trials/quetiapine-for-the-treatment-of-insomnia-in-alzheimer-s-disease-65458 https://curecurrent.com/trials/bonsai-biomarkers-of-nonsteroidal-anti-inflammatories-65459 https://curecurrent.com/trials/anti-oxidant-treatment-of-alzheimer-s-disease-65460 https://curecurrent.com/trials/investigation-of-lithium-on-signal-transduction-gene-expression-and-brain-myo-inositol-levels-in-manic-patients-65461 https://curecurrent.com/trials/seroquel-agitation-associated-with-dementia-65462 https://curecurrent.com/trials/donepezil-and-memantine-in-moderate-to-severe-alzheimer-s-disease-65463 https://curecurrent.com/trials/bathing-persons-with-alzheimer-s-disease-at-home-the-bath-study-65464 https://curecurrent.com/trials/a-phase-1-study-to-evaluate-the-effect-of-dimebon-on-the-pharmacokinetics-of-dextromethorphan-65465 https://curecurrent.com/trials/mirage-multi-institutional-research-in-alzheimer-s-genetic-epidemiology-65466 https://curecurrent.com/trials/observational-study-on-costs-and-caregiver-burden-in-alzheimer-s-disease-65467 https://curecurrent.com/trials/a-pilot-study-of-inflammatory-markers-in-alzheimer-s-disease-65468 https://curecurrent.com/trials/study-evaluating-the-safety-tolerability-and-activity-of-one-dose-of-paz-417-given-to-healthy-japanese-subjects-65469 https://curecurrent.com/trials/effects-of-a-complex-cognitive-training-in-mild-cognitive-impairment-and-mild-alzheimer-s-disease-65470 https://curecurrent.com/trials/memory-imaging-of-normal-aging-65471 https://curecurrent.com/trials/positron-emission-tomography-pet-study-with-11c-azd2995-and-11c-azd2184-candidate-pet-ligands-for-amyloid-65472 https://curecurrent.com/trials/alzheimer-s-disease-and-aging-therapeutic-potential-of-estrogen-65473 https://curecurrent.com/trials/gene-environment-interactions-in-alzheimer-s-disease-65474 https://curecurrent.com/trials/insulin-neurogenetics-and-memory-in-alzheimer-s-disease-65475 https://curecurrent.com/trials/electrophysiologic-measures-of-treatment-response-in-alzheimer-disease-65476 https://curecurrent.com/trials/specific-interventions-for-agitation-in-alzheimer-s-disease-65477 https://curecurrent.com/trials/effects-of-estrogen-on-memory-in-post-menopausal-women-and-patients-with-alzheimer-s-disease-65478 https://curecurrent.com/trials/memantine-versus-donepezil-in-early-stages-of-alzheimer-s-disease-65479 https://curecurrent.com/trials/a-study-to-assess-the-pharmacokinetics-of-sb-742457-formulated-as-a-capsule-and-a-tablet-in-healthy-elderly-volunteers-65480 https://curecurrent.com/trials/long-term-safety-extension-with-sr57667b-in-patients-with-alzheimer-s-disease-65481 https://curecurrent.com/trials/activity-of-ave1625-in-mild-to-moderate-alzheimer-s-patients-65482 https://curecurrent.com/trials/drug-interaction-study-between-azd3480-and-cytochrome-p450-65483 https://curecurrent.com/trials/drug-interaction-study-with-a-potential-alzheimer-s-disease-compound-65484 https://curecurrent.com/trials/safety-of-three-formulations-of-ketasyn-administered-for-14-days-in-healthy-elderly-65485 https://curecurrent.com/trials/a-study-of-healthy-subjects-to-assess-the-effect-of-ly450139-on-amyloid-beta-peptide-production-rate-and-or-dose-respons-65486 https://curecurrent.com/trials/systematic-care-for-informal-caregivers-of-dementia-patients-an-efficient-approach-65487 https://curecurrent.com/trials/study-evaluating-potential-pharmacokinetic-pk-interaction-between-lecozotan-and-digoxin-65488 https://curecurrent.com/trials/brain-imaging-and-mental-disorders-of-aging-intervention-65489 https://curecurrent.com/trials/tracking-technologies-for-the-analysis-of-mobility-in-alzheimer-s-disease-65490 https://curecurrent.com/trials/18-month-study-of-the-efficacy-of-xaliproden-sr57746a-in-patients-with-mild-to-moderate-dementia-of-the-alzheimer-s-type-65491 https://curecurrent.com/trials/study-of-xaliproden-sr57746a-in-patients-with-mild-to-moderate-dementia-of-the-alzheimer-s-type-65492 https://curecurrent.com/trials/european-study-of-hf0220-in-mild-to-moderate-alzheimer-s-disease-patients-65493 https://curecurrent.com/trials/global-efficacy-study-of-mpc-7869-to-treat-patients-with-alzheimer-s-65494 https://curecurrent.com/trials/open-label-treatment-with-mpc-7869-for-patients-with-alzheimer-s-who-previously-participated-in-an-mpc-7869-protocol-65495 https://curecurrent.com/trials/study-evaluating-gsi-953-in-healthy-young-and-alzheimer-s-patients-65496 https://curecurrent.com/trials/study-evaluating-safety-tolerability-pharmacokinetics-and-5-ht1a-receptor-occupancy-65497 https://curecurrent.com/trials/safety-study-of-cts21166-to-treat-alzheimer-disease-65498 https://curecurrent.com/trials/evaluation-of-123i-av83-and-spect-in-patients-with-alzheimer-disease-in-comparison-to-healthy-controls-65499 https://curecurrent.com/trials/safety-and-efficacy-of-mem-3454-versus-placebo-in-patients-with-mild-to-moderate-alzheimer-s-disease-65500 https://curecurrent.com/trials/safety-and-efficacy-of-mem-1003-versus-placebo-in-patients-with-mild-to-moderate-alzheimer-s-disease-65501 https://curecurrent.com/trials/a-pilot-study-of-curcumin-and-ginkgo-for-treating-alzheimer-s-disease-65502 https://curecurrent.com/trials/use-of-123i-av39-and-spect-imaging-as-a-marker-of-protein-disposition-in-subjects-with-alzheimer-disease-compared-to-hea-65503 https://curecurrent.com/trials/study-evaluating-effects-of-sam-531-on-sleep-electroencephalogram-eeg-and-quantitative-wake-eeg-in-healthy-subjects-65504 https://curecurrent.com/trials/the-relationship-between-risperdal-treatment-and-quality-of-life-in-patients-with-alzheimer-s-disease-and-behavioural-an-65505 https://curecurrent.com/trials/brain-imaging-in-alzheimer-s-disease-65506 https://curecurrent.com/trials/effect-of-lithium-and-divalproex-in-alzheimer-s-disease-65507 https://curecurrent.com/trials/preliminary-study-of-fish-oil-and-dementia-65508 https://curecurrent.com/trials/genetic-studies-in-alzheimer-s-disease-65509 https://curecurrent.com/trials/the-effect-of-short-term-statins-and-nsaids-on-levels-of-beta-amyloid-a-protein-associated-with-alzheimer-s-disease-65510 https://curecurrent.com/trials/pet-scan-of-brain-metabolism-in-relation-to-age-and-disease-65511 https://curecurrent.com/trials/treatment-of-alzheimer-s-disease-with-cx516-ampalex-65512 https://curecurrent.com/trials/nefiracetam-in-the-treatment-of-alzheimer-s-disease-65513 https://curecurrent.com/trials/diagnosis-and-natural-history-study-of-patients-with-neurological-conditions-65514 https://curecurrent.com/trials/brain-imaging-in-elderly-people-and-individuals-with-alzheimer-s-disease-65515 https://curecurrent.com/trials/the-effect-of-acetylcholine-on-memory-and-attention-65516 https://curecurrent.com/trials/an-innovative-psychosocial-intervention-for-adult-child-caregivers-of-parents-with-alzheimer-s-disease-65517 https://curecurrent.com/trials/huperzine-a-in-alzheimer-s-disease-65518 https://curecurrent.com/trials/trx0014-in-patients-with-mild-or-moderate-alzheimer-s-disease-65519 https://curecurrent.com/trials/study-evaluating-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-sam-315-65520 https://curecurrent.com/trials/treatment-with-copper-in-patients-with-mild-alzheimer-s-dementia-65521 https://curecurrent.com/trials/prevention-of-cognitive-decline-in-alzheimer-s-disease-by-ingested-interferon-alpha-65522 https://curecurrent.com/trials/a-randomized-placebo-controlled-trial-to-examine-the-efficacy-of-oral-donepezil-in-subjects-with-mci-65523 https://curecurrent.com/trials/safety-efficacy-pharmacokinetics-and-pharmacodynamics-study-of-bryostatin-1-in-patients-with-alzheimer-s-disease-65524 https://curecurrent.com/trials/short-term-effects-of-prx-03140-in-patients-with-mild-alzheimer-s-disease-being-treated-with-aricept-65525 https://curecurrent.com/trials/study-evaluating-the-safety-tolerability-and-efficacy-of-pbt2-in-patients-with-early-alzheimer-s-disease-65526 https://curecurrent.com/trials/study-of-memantine-in-assessment-of-selected-measures-of-volumetric-magnetic-resonance-imaging-mri-and-cognition-in-mode-65527 https://curecurrent.com/trials/the-impact-of-lorazepam-on-cognition-in-apoe-e4-carriers-65528 https://curecurrent.com/trials/study-evaluating-the-effect-of-lecozotan-sr-on-the-qtc-interval-65529 https://curecurrent.com/trials/safety-and-tolerability-of-rivastigmine-with-add-on-memantine-in-patients-with-probable-alzheimer-s-disease-65530 https://curecurrent.com/trials/study-of-the-effects-of-current-drug-treatments-on-levels-of-certain-brain-chemicals-in-alzheimer-s-disease-65531 https://curecurrent.com/trials/efficacy-and-safety-of-rivastigmine-in-patients-with-mild-cognitive-impairment-65532 https://curecurrent.com/trials/study-evaluating-the-safety-pharmacokinetics-and-pharmacodynamics-of-sam-531-in-healthy-young-and-elderly-subjects-65533 https://curecurrent.com/trials/study-evaluating-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-sam-531-in-healthy-subjects-65534 https://curecurrent.com/trials/european-study-of-3aps-in-mild-to-moderate-alzheimer-s-disease-patients-65535 https://curecurrent.com/trials/study-comparing-lecozotan-sr-two-5-mg-tablets-vs-lecozotan-sr-one-10-mg-tablet-in-healthy-subjects-65536 https://curecurrent.com/trials/study-evaluating-the-safety-tolerability-pharmacokinetics-pk-and-pharmacodynamics-pd-of-sam-315-in-healthy-adults-65537 https://curecurrent.com/trials/single-ascending-dose-study-of-sra-444-in-healthy-subjects-65538 https://curecurrent.com/trials/study-evaluating-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-sam-315-in-healthy-japanese-males-65539 https://curecurrent.com/trials/the-effect-of-anticholinesterase-drugs-on-sleep-in-alzheimer-s-disease-patients-65540 https://curecurrent.com/trials/adding-atomoxetine-to-standard-medication-treatment-in-patients-with-alzheimer-s-disease-65541 https://curecurrent.com/trials/dopaminergic-enhancement-of-learning-and-memory-in-healthy-adults-and-patients-with-dementia-mild-cognitive-impairment-65542 https://curecurrent.com/trials/the-effect-of-melatonin-on-cognitive-function-in-patients-diagnosed-with-mild-cognitive-impairment-65543 https://curecurrent.com/trials/pet-study-of-the-nicotinic-receptors-in-human-65544 https://curecurrent.com/trials/the-serotonergic-transmitter-system-in-dementia-and-affective-disorders-65545 https://curecurrent.com/trials/couples-coping-with-alzheimer-s-disease-65546 https://curecurrent.com/trials/aladdin-study-phase-iii-antigonadotropin-leuprolide-in-alzheimer-s-disease-drug-investigation-vp-ad-301-65547 https://curecurrent.com/trials/healthy-aging-and-memory-study-65548 https://curecurrent.com/trials/diffusion-tensor-weighted-mri-in-alzheimer-s-disease-modifying-treatment-effects-of-galantamine-reminyl-65549 https://curecurrent.com/trials/open-label-extension-of-the-phase-iii-study-with-tramiprosate-3aps-in-patients-with-mild-to-moderate-alzheimer-s-disease-65550 https://curecurrent.com/trials/effects-of-ly450139-dihydrate-on-subjects-with-mild-to-moderate-alzheimer-s-disease-65551 https://curecurrent.com/trials/combining-a-caregiver-intervention-with-aricept-treatment-for-mild-to-moderate-alzheimer-s-disease-65552 https://curecurrent.com/trials/gts21-201-for-alzheimer-disease-gts-21-administered-daily-for-28-days-to-participants-with-probable-alzheimer-s-disease-65553 https://curecurrent.com/trials/study-evaluating-the-safety-of-lecozotan-sr-in-healthy-young-and-elderly-subjects-65554 https://curecurrent.com/trials/evaluating-the-effects-of-music-interventions-on-hospitalised-people-with-dementia-65555 https://curecurrent.com/trials/evaluation-of-3aps-in-patients-with-mild-to-moderate-alzheimer-s-disease-65556 https://curecurrent.com/trials/effect-of-indomethacin-on-the-progression-of-alzheimer-s-disease-65557 https://curecurrent.com/trials/pact-providers-and-alzheimer-s-caregivers-together-65558 https://curecurrent.com/trials/lipitor-as-a-treatment-for-alzheimer-s-disease-65559 https://curecurrent.com/trials/effect-of-panax-ginseng-on-the-cognitive-performance-in-alzheimer-s-disease-65560 https://curecurrent.com/trials/safety-study-of-ppi-1019-in-subjects-with-mild-moderate-alzheimer-s-disease-65561 https://curecurrent.com/trials/safety-study-of-ppi-1019-in-patients-with-mild-moderate-alzheimer-s-disease-65562 https://curecurrent.com/trials/cognishunt-system-for-alzheimer-s-disease-65563 https://curecurrent.com/trials/positron-emission-tomography-of-amyloid-in-alzheimer-s-disease-65564 https://curecurrent.com/trials/a-study-of-the-safety-and-efficacy-of-multiple-doses-of-abt-089-in-subjects-with-alzheimer-s-disease-65565 https://curecurrent.com/trials/study-of-escitalopram-versus-placebo-in-the-treatment-of-depressive-syndrome-in-alzheimer-s-disease-vascular-dementia-an-65566 https://curecurrent.com/trials/care-management-for-patients-with-alzheimer-disease-and-their-family-caregivers-65567 https://curecurrent.com/trials/high-intensity-light-therapy-in-alzheimer-s-disease-65568 https://curecurrent.com/trials/efficacy-and-safety-of-ly451395-in-patients-with-probable-alzheimer-s-disease-65569 https://curecurrent.com/trials/tnf-alpha-inhibition-for-treatment-of-alzheimer-s-disease-65570 https://curecurrent.com/trials/tnf-alpha-inhibition-for-treatment-of-alzheimer-s-disease-65571 https://curecurrent.com/trials/study-of-the-effect-of-sr57667b-in-patients-with-alzheimer-s-disease-65572 https://curecurrent.com/trials/mrs-and-dti-of-white-matter-in-alzheimer-s-disease-65573 https://curecurrent.com/trials/calm-ad-65574 https://curecurrent.com/trials/metabolic-syndrome-inflammation-and-risk-of-cognitive-decline-65575 https://curecurrent.com/trials/influence-of-age-on-hemispheric-lateralization-of-language-a-longitudinal-study-65576 https://curecurrent.com/trials/double-blind-study-of-trp01-in-patients-with-alzheimer-s-disease-65577 https://curecurrent.com/trials/pain-perception-in-alzheimer-s-disease-65578 https://curecurrent.com/trials/coordinating-center-for-enhancing-adrd-caregiving-65579 https://curecurrent.com/trials/efficacy-and-safety-study-of-dcb-ad1-in-patients-with-mild-to-moderate-alzheimer-s-disease-65580 https://curecurrent.com/trials/multicenter-trial-of-prednisone-in-alzheimer-s-disease-65581 https://curecurrent.com/trials/investigation-into-delay-to-diagnosis-of-alzheimer-s-disease-with-exelon-inddex-65582 https://curecurrent.com/trials/study-of-melatonin-sleep-problems-in-alzheimer-s-disease-65583 https://curecurrent.com/trials/agitation-in-alzheimer-s-disease-65584 https://curecurrent.com/trials/evaluation-of-galantamine-in-the-treatment-of-alzheimer-s-disease-65585 https://curecurrent.com/trials/single-center-study-of-gustation-in-idiopathic-parkinson-s-disease-and-lewy-body-disease-using-gustatory-evoked-potentia-65586 https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-carbidopa-levodopa-extended-release-tablets-in-patients-with-parkinson-s-disease-65587 https://curecurrent.com/trials/clinical-trial-evaluating-the-efficacy-and-safety-of-agb101-for-treatment-of-parkinson-s-disease-related-psychosis-65588 https://curecurrent.com/trials/tributyrin-for-progressive-supranuclear-palsy-psp-virtual-trial-65589 https://curecurrent.com/trials/bilateral-closed-loop-deep-brain-stimulation-for-freezing-of-gait-using-neural-and-kinematic-feedback-65590 https://curecurrent.com/trials/the-effect-of-functional-rotational-exercises-on-fall-risk-and-mobility-in-parkinson-s-disease-patients-65591 https://curecurrent.com/trials/feasibility-and-safety-of-a-portable-exoskeleton-to-improve-mobility-in-parkinson-s-disease-65592 https://curecurrent.com/trials/terazosin-and-metabolic-engagement-in-parkinson-s-disease-65593 https://curecurrent.com/trials/short-term-effects-of-a-multimodal-intervention-with-rgm-on-cognition-in-people-with-parkinson-s-disease-65594 https://curecurrent.com/trials/deep-brain-stimulation-dbs-retrospective-outcomes-study-65595 https://curecurrent.com/trials/substudy-06c-a-study-of-investigational-agents-with-pembrolizumab-mk-3475-and-chemotherapy-in-participants-with-first-li-65596 https://curecurrent.com/trials/extended-reality-rehabilitation-in-parkinson-s-disease-65597 https://curecurrent.com/trials/a-study-to-evaluate-investigational-agents-with-or-without-pembrolizumab-mk-3475-in-participants-with-advanced-esophagea-65598 https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-intravenous-iv-prasinezumab-in-participants-with-early-stage-parkinson-s-65599 https://curecurrent.com/trials/long-term-observational-study-on-effectiveness-and-safety-of-lecigon-in-patients-with-advanced-parkinson-s-disease-65600 https://curecurrent.com/trials/effect-of-physical-activity-on-the-course-of-parkinson-s-disease-in-patients-with-bilateral-dbs-stn-stimulation-65601 https://curecurrent.com/trials/home-based-exercise-program-after-community-balance-training-for-parkinson-s-disease-65602 https://curecurrent.com/trials/kinematic-and-neural-dynamics-of-postural-instability-in-parkinson-s-disease-65603 https://curecurrent.com/trials/swallowfit-study-in-parkinson-s-disease-65604 https://curecurrent.com/trials/a-study-to-evaluate-the-effectiveness-of-two-doses-of-ap-472-as-adjunctive-therapy-to-levodopa-in-parkinson-s-disease-pd-65605 https://curecurrent.com/trials/a-clinical-study-of-sacituzumab-tirumotecan-mk-2870-in-combination-with-pembrolizumab-mk-3475-as-first-line-maintenance-65606 https://curecurrent.com/trials/a-study-to-compare-sacituzumab-tirumotecan-mk-2870-in-combination-with-pembrolizumab-mk-3475-versus-pembrolizumab-alone-65607 https://curecurrent.com/trials/effects-of-mental-imagery-with-self-regulation-on-daily-activities-in-people-with-parkinson-s-disease-65608 https://curecurrent.com/trials/closed-loop-programming-evaluation-using-external-responses-for-deep-brain-stimulation-65609 https://curecurrent.com/trials/temporal-interference-stimulation-for-motor-and-non-motor-symptoms-in-parkinson-s-disease-65610 https://curecurrent.com/trials/a-study-to-investigate-the-pharmacokinetics-and-safety-of-subcutaneous-rilvegostomig-in-adult-participants-with-advanced-65611 https://curecurrent.com/trials/pet-scanning-in-parkinson-s-disease-65612 https://curecurrent.com/trials/engage-pd-a-physical-activity-coaching-program-via-telehealth-for-people-with-parkinson-s-disease-a-single-cohort-study-65613 https://curecurrent.com/trials/spinal-mobility-rigidity-and-kinesiophobia-in-pd-and-tmd-65614 https://curecurrent.com/trials/ai-based-differential-diagnosis-and-localization-of-tachycardia-using-ecg-multicenter-registry-ep-ai-assist-65615 https://curecurrent.com/trials/agricultural-health-study-follow-up-65616 https://curecurrent.com/trials/a-phase-2-study-and-open-label-extension-of-neu-411-in-companion-diagnostic-positive-participants-with-early-parkinson-s-65617 https://curecurrent.com/trials/a-study-of-pembrolizumab-mk-3475-in-combination-with-belzutifan-mk-6482-and-lenvatinib-mk-7902-or-pembrolizumab-quavonli-65618 https://curecurrent.com/trials/enabling-women-with-parkinson-s-disease-to-identify-and-better-manage-hormonal-triggers-of-parkinsonian-symptoms-65619 https://curecurrent.com/trials/a-pilot-study-to-investigate-the-safety-and-clinical-activity-of-avelumab-msb0010718c-in-thymoma-and-thymic-carcinoma-af-65620 https://curecurrent.com/trials/long-term-effectiveness-of-levodopa-entacapone-carbidopa-intestinal-gel-in-participants-with-advanced-parkinson-s-diseas-65621 https://curecurrent.com/trials/real-world-patient-experiences-with-inbrija-65622 https://curecurrent.com/trials/study-to-assess-real-life-effectiveness-of-foslevodopa-foscarbidopa-in-adult-german-participants-at-initial-stages-of-ad-65623 https://curecurrent.com/trials/montelukast-in-parkinson-disease-65624 https://curecurrent.com/trials/artificial-intelligence-based-parkinson-s-disease-risk-assessment-ai-pra-study-65625 https://curecurrent.com/trials/computer-assisted-self-training-to-improve-executive-function-65626 https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-aci-7104-056-in-patients-with-early-stages-of-parkinson-s-disease-65627 https://curecurrent.com/trials/occupation-based-cognitive-stimulation-with-and-without-motivational-feedback-in-parkinson-s-disease-65628 https://curecurrent.com/trials/motor-network-physiology-65629 https://curecurrent.com/trials/sustained-release-oral-formulation-for-treatment-of-parkinsons-disease-65630 https://curecurrent.com/trials/a-study-of-aav2-gdnf-in-adults-with-moderate-parkinson-s-disease-regenerate-pd-65631 https://curecurrent.com/trials/feasibility-of-a-community-based-multimodal-exercise-programme-in-parkinson-s-disease-65632 https://curecurrent.com/trials/a-clinical-trial-of-ly3962681-in-healthy-volunteers-and-in-patients-with-parkinson-s-disease-65633 https://curecurrent.com/trials/upper-extremity-skills-trunk-control-and-body-awareness-in-parkinson-s-disease-65634 https://curecurrent.com/trials/the-role-of-priors-in-hallucinatory-perception-in-parkinson-s-disease-65635 https://curecurrent.com/trials/study-of-the-test-retest-reliability-of-the-neuropsychiatric-fluctuations-scale-in-parkinson-39-s-disease-65636 https://curecurrent.com/trials/unlocking-movement-potential-enhancing-parkinson-s-disease-treatment-with-robotic-eksoskeleton-65637 https://curecurrent.com/trials/the-safety-tolerability-efficacy-of-xs411-cell-injection-for-the-treatment-of-primary-parkinson-s-disease-65638 https://curecurrent.com/trials/visual-hallucinations-in-lewy-body-diseases-65639 https://curecurrent.com/trials/pembrolizumab-plus-epacadostat-pembrolizumab-monotherapy-and-the-extreme-regimen-in-recurrent-or-metastatic-head-and-nec-65640 https://curecurrent.com/trials/the-effects-of-ischemic-conditioning-in-individuals-with-parkinson-s-disease-65641 https://curecurrent.com/trials/deep-brain-stimulation-therapy-in-movement-disorders-65642 https://curecurrent.com/trials/evaluation-and-treatment-of-neurosurgical-disorders-65643 https://curecurrent.com/trials/a-manualized-recreational-therapy-balance-program-for-older-adults-with-parkinson-s-and-movement-disorders-65644 https://curecurrent.com/trials/the-parkinson-s-disease-case-control-study-65645 https://curecurrent.com/trials/effects-of-excitatory-and-inhibitory-lifus-of-gpi-in-parkinsonian-patients-without-dbs-65646 https://curecurrent.com/trials/a-study-to-determine-if-bhv-8000-is-effective-safe-and-tolerable-as-a-treatment-for-adults-living-with-early-parkinson-s-65647 https://curecurrent.com/trials/imaging-biomarkers-in-parkinson-s-disease-65648 https://curecurrent.com/trials/a-clinical-study-of-intismeran-autogene-v940-and-pembrolizumab-mk-3475-in-people-with-melanoma-v940-012-interpath-012-65649 https://curecurrent.com/trials/pulmonary-and-musculoskeletal-impairments-in-parkinson-s-patients-65650 https://curecurrent.com/trials/positron-emission-tomography-pet-imaging-in-people-with-gaucher-mutations-65651 https://curecurrent.com/trials/velocity-loss-training-and-parkinson-s-disease-65652 https://curecurrent.com/trials/long-term-follow-up-ket-pd-65653 https://curecurrent.com/trials/bayesian-optimization-of-dbs-for-gait-65654 https://curecurrent.com/trials/the-efficacy-of-psilocybin-therapy-for-depression-in-parkinson-s-disease-65655 https://curecurrent.com/trials/clinical-laboratory-evaluation-of-chronic-autonomic-failure-65656 https://curecurrent.com/trials/gbpdc-gut-brain-in-pd-consortium-master-protocol-65657 https://curecurrent.com/trials/a-two-part-single-and-multiple-ascending-dose-trial-of-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-65658 https://curecurrent.com/trials/substudy-03a-a-study-of-immune-and-targeted-combination-therapies-in-participants-with-first-line-1l-renal-cell-carcinom-65659 https://curecurrent.com/trials/substudy-03b-a-study-of-immune-and-targeted-combination-therapies-in-participants-with-second-line-plus-2l-renal-cell-ca-65660 https://curecurrent.com/trials/multicenter-implementation-of-e-monitoring-in-parkinson-s-disease-65661 https://curecurrent.com/trials/acute-effects-of-capacitive-resistive-radiofrequency-therapy-in-people-with-parkinson-s-disease-65662 https://curecurrent.com/trials/assessment-of-the-safety-immunogenicity-and-pharmacodynamics-of-trb-001-in-patients-with-early-idiopathic-parkinson-s-di-65663 https://curecurrent.com/trials/investigating-adaptive-deep-brain-stimulation-in-parkinson-s-disease-management-65664 https://curecurrent.com/trials/terazosin-and-metabolic-energetics-in-parkinson-s-disease-65665 https://curecurrent.com/trials/efficacy-of-repetitive-transcranial-magnetic-stimulation-for-improving-depressive-symptoms-in-patients-with-parkinson-s-65666 https://curecurrent.com/trials/a-12-week-study-of-flexilev-with-the-orafid-device-and-app-in-parkinson-s-patients-65667 https://curecurrent.com/trials/sensory-filtering-in-the-human-basal-ganglia-as-a-mechanism-of-parkinson-s-disease-65668 https://curecurrent.com/trials/medipd-an-online-mediterranean-diet-program-for-people-living-with-parkinson-s-disease-65669 https://curecurrent.com/trials/effects-of-transcutaneous-cervical-vagus-nerve-stimulation-on-non-motor-symptoms-in-parkinson-s-disease-65670 https://curecurrent.com/trials/a-study-of-zanidatamab-in-combination-with-chemotherapy-plus-or-minus-tislelizumab-in-patients-with-her2-positive-advanc-65671 https://curecurrent.com/trials/istradefylline-for-parkinson-disease-with-cognitive-impairment-65672 https://curecurrent.com/trials/effects-of-repetitive-transcranial-magnetic-stimulation-rtms-primed-self-controlled-practice-in-people-with-parkinson-s-65673 https://curecurrent.com/trials/remotely-supervised-home-based-transcranial-temporal-interference-stimulation-on-motor-symptoms-in-parkinson-s-disease-65674 https://curecurrent.com/trials/effect-of-botulinum-toxin-on-resting-tremor-of-the-refractory-upper-limb-in-parkinsonians-65675 https://curecurrent.com/trials/genetic-studies-of-lysosomal-storage-disorders-65676 https://curecurrent.com/trials/boxing-based-training-to-improve-balance-and-mobility-in-parkinson-s-disease-65677 https://curecurrent.com/trials/integrated-motor-cognitive-training-in-parkinson-s-disease-a-feasibility-study-65678 https://curecurrent.com/trials/speech-learning-and-speech-production-in-parkinson-s-disease-65679 https://curecurrent.com/trials/asymmetric-targeted-dbs-for-pd-with-pigd-65680 https://curecurrent.com/trials/ancillary-study-no-3-ns-park-omics-65681 https://curecurrent.com/trials/balance-performance-and-quality-of-life-in-parkinson-s-disease-65682 https://curecurrent.com/trials/neurophysiology-biomarkers-of-cognitive-impairment-associated-with-deep-brain-stimulation-65683 https://curecurrent.com/trials/dual-task-balance-and-gait-training-combined-with-cognitive-training-in-parkinson-s-patients-65684 https://curecurrent.com/trials/blood-flow-restriction-aerobic-exercise-for-balance-and-anxiety-in-parkinson-s-disease-65685 https://curecurrent.com/trials/study-to-test-effects-and-safety-of-ro7568282-in-early-parkinson-s-disease-65686 https://curecurrent.com/trials/a-study-of-buntanetap-in-participants-with-pd-65687 https://curecurrent.com/trials/first-in-human-study-of-aln-snca-in-adult-participants-with-early-parkinson-s-disease-pd-65688 https://curecurrent.com/trials/this-protocol-is-a-sub-study-under-the-ppmi-program-it-is-a-longitudinal-single-center-study-to-assess-the-performance-o-65689 https://curecurrent.com/trials/low-dose-carbon-monoxide-hbi-002-trial-to-evaluate-safety-tolerability-pk-and-biomarkers-in-parkinson-s-disease-65690 https://curecurrent.com/trials/spinal-cord-stimulation-for-freezing-of-gait-in-parkinson-s-disease-65691 https://curecurrent.com/trials/mri-guided-temporal-interference-stimulation-for-parkinson-s-disease-65692 https://curecurrent.com/trials/new-approaches-in-mri-at-3t-dedicated-to-targeting-subthalamic-nucleus-on-parkinsonian-patients-65693 https://curecurrent.com/trials/passive-versus-active-music-therapy-parkinson-s-disease-65694 https://curecurrent.com/trials/analysis-of-cutaneous-phosphorylated-alpha-synuclein-to-identify-patients-at-risk-of-progressing-from-essential-tremor-t-65695 https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-in-combination-with-adjuvant-chemotherapy-with-or-without-radiotherapy-in-participants-wi-65696 https://curecurrent.com/trials/neurodegenerative-diseases-registry-65697 https://curecurrent.com/trials/clinical-and-physiological-studies-of-tremor-syndromes-65698 https://curecurrent.com/trials/physiological-investigations-of-movement-disorders-65699 https://curecurrent.com/trials/natural-history-protocol-for-movement-disorders-65700 https://curecurrent.com/trials/stimulating-specific-brain-areas-vop-vim-with-electricity-to-improve-movement-and-muscle-control-65701 https://curecurrent.com/trials/atr-1072-in-participants-with-prkag2-syndrome-65702 https://curecurrent.com/trials/vismemopd-protocol-an-observational-pilot-study-on-spatial-and-topographical-memory-in-patients-with-parkinson-s-disease-65703 https://curecurrent.com/trials/neuroplasticity-in-parkinson-s-disease-65704 https://curecurrent.com/trials/resveratrol-in-parkinson-s-disease-reset-65705 https://curecurrent.com/trials/phase-1-2a-clinical-trial-of-pr001-ly3884961-in-patients-with-parkinson-s-disease-with-at-least-one-gba1-mutation-propel-65706 https://curecurrent.com/trials/hereditary-parkinson-s-disease-natural-history-protocol-65707